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ABSTRACT 
 
The pks genes are the largest antibiotic- encoding gene cluster in Bacillus subtilis 
and encode the Pks enzymatic complex that produces bacillaene. Bacillaene plays 
important roles in the fitness of B. subtilis during competition with other bacterial 
species.  
In this dissertation, I investigate the regulatory mechanisms used by B. subtilis to 
control the expression of the pks genes and the production of bacillaene.  First, I focus 
on understanding the transcriptional regulatory network that coordinates the activation of 
the pks genes. My results indicate that multiple transcriptional regulators, in particular 
the stationary phase regulators Spo0A and CodY, coordinate the control of the pks gene 
activation. Also, cells dedicated to the formation of biofilms and spores but not motility 
induce the expression of the pks genes. I discuss these findings in light of their roles 
during bacterial competition.  
I also identified multiple regulatory elements along the pks genes. Promoters 
upstream of pksB, pksC and pksS are active during vegetative growth while a promoter 
upstream of pksG is active only during spore formation. The activity of the pksG 
promoter is exclusive to the nascent spores and not the mother cells. In addition to 
promoters, a cis-regulatory element at the intergenic region of pksC and pksD promotes 
readthrough of transcription terminators along the pks genes. 
Finally, I focus on the function of PksA, previously presumed to regulate the pks 
genes. I have found that PksA is not involved in the control of the pks gene expression. 
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Instead, PksA negatively regulates the expression of ymcC. My data suggests that YmcC 
is not involved in bacillaene production but, consistent with structural prediction, I have 
found that YmcC is a membrane protein produced during sporulation. I hypothesize the 
function of YmcC during spore maturation or germination and propose experiments to 
elucidate this role.  
In general, this dissertation contributes to the understanding of pks gene 
regulation and its implications in the competitive fitness of B. subtilis. This work also 
provides a model for the activation of Type I trans-AT PKSs encoded in gene clusters 
with similar organization to the pks genes. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Secondary metabolites were considered for long time as small molecules that are 
dispensable for growth and reproduction of the organisms that synthesize them, 
contrasting with the essential primary metabolites (1). Kossel, a German plant 
physiologist that was trying to classify compounds produced by plants, introduced the 
terms “primary” and “secondary” metabolites for the first time in 1891. He called 
“primary” those metabolites that were present in all living organisms and therefore he 
considered essential for survival. Given that Kossel found an increasing number of 
compounds that were distinctive to individual species, he decided to group them as 
“secondary metabolites” or dispensable by-products of central metabolism (2).  
Secondary metabolites are widespread and abundant in nature, suggesting that 
they provide important functions to the organisms that synthesize them. It is estimated 
that a wide number of plants produce, as a group, over 22,000 different secondary 
metabolites (3). In addition, rough calculations predict more than 50,000 different 
secondary metabolites produced by fungi and bacteria. Seventeen percent of known 
secondary metabolites produced by microbes are synthesized by molds while 
filamentous bacteria belonging to the group of actinomycetes produce seventy four 
percent of these natural compounds (3). Therefore, secondary metabolites have gained 
recognition over time and their beneficial roles for the organisms that produce them are 
an active area of investigation (4, 5). 
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Broad evidence indicates that secondary metabolites have a variety of biological 
roles in nature.  The effects of secondary metabolites depend on their chemical structure, 
concentration and composition of the biotic surroundings. Secondary metabolites can be 
involved in monitoring cell density, growth coordination, virulence, bacterial 
communication and competition (3–6). However, the most extensive studies have been 
done in the role of secondary metabolites as antibiotics, antitumor, antiviral and other 
properties related with medicinal uses.  
 
Significance of antibiotics 
Antibiotics were first discovered in the mid 1930’s of the last century with such 
success that they were considered the cure of the infectious diseases. In 1929, the 
Scottish scientist Alexander Fleming observed that his cultures of Staphylococcus 
aureus were contaminated with a mold, Penicillium notatum, which inhibited the growth 
of S. aureus. Fleming was able to separate the mold cells from the liquid medium that 
contained the active ingredient, and called this ingredient Penicillin. By 1943, the 
production of Penicillin was industrialized and the compound was successfully used to 
treat wound infections during World War II (7). In the same year, the laboratory of 
Selman Abraham Waksman, at Rutgers University, isolated a compound with antibiotic 
properties from actinomycetes. The compound was named streptomycin and became the 
first antibiotic to cure tuberculosis. Waksman research also led to the recognition that the 
filamentous bacteria that belong to actinomycetes are the most prolific producers of 
  3 
antibiotics (8). Today, hundreds of antibiotics are approved to treat bacterial infections 
that affect humans, animals and plants (3).  
In spite of the success antibiotics have had to treat infections, pathogenic bacteria 
have been able to counteract antibiotics by developing resistance against them. By 
chromosomal mutation or exchange in genetic material, bacteria have been able to 
overcome antibiotic effects by inactivating of the compound, preventing of access to the 
target or altering of the antibiotic target site (9).  Unfortunately, antibiotic discovery has 
not kept pace with resistance. The cases of common infections that do not respond to 
conventional antibiotic treatment are increasing every year. The increasing resistance 
offsets the growing collection of antibiotics over time. A worldwide alarm has risen to 
search for new strategies in order to keep fighting this battle (10, 11). 
The rate of new antibiotic development has also steeply declined (12). Since the 
early 1980s, the US Food and Drug Administration has approved fewer antibiotics for 
clinical trials. For example, nineteen new drug applications were approved in the early 
1980s, but just three new ones were approved from 2005-2009, showing a marked 
decrease in new antibiotic development (13). The technical difficulty in identifying and 
developing truly novel and clinically useful antibiotics is the most significant factor (12).   
According to predictions based on bacterial genome capacity, our current stock 
of antibiotics is just a minimal fraction of antimicrobial compounds that can be isolated 
(14, 15). However, the majority of gene clusters that encode for antibiotics remain silent 
under standard laboratory conditions due, in part, to our insufficient knowledge about 
the environmental signals and metabolic networks that activate antibiotic synthesis 
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pathways in bacteria (16). Therefore, it is imperative to increase our understanding of 
how bacteria respond to their biotic and abiotic surroundings, adapt their general 
metabolism and couple such metabolism with activation of antibiotic synthesis. 
 
Structure and biosynthesis of antibiotics is broadly diverse 
The diversity and abundance of structures in different families of antibiotics is 
remarkable. These small molecule families differ from each other, not only in their 
backbone structures, but also in their biosynthesis (17).  In the case of non-ribosomal 
peptides and polyketides, the largest and most studied families of antibiotics, the variety 
of chemical structures is related to the combinatorial utilization of chemical building 
blocks that are put together by enzyme complexes.  
Peptides, the most abundant family of compounds with antimicrobial activity, are 
usually cyclic, with highly hydrophobic character, and generally resistant to peptidases 
and proteases due to the presence of D-amino acids (18, 19). Two different mechanisms 
may lead to the synthesis of these unconventional small peptides.  Ribosomes may 
synthesize small peptides that are subsequently subjected to post-translation 
modifications.  These small compounds synthesized by ribosomes are usually called 
bacteriocins. Alternatively, antimicrobial peptides might also be produced by large non-
ribosomal peptide synthetases (NRPS). NRPSs coordinate multistep catalytic activities 
of highly conserved domains that recognize different amino acid substrates to activate 
them and condense them into the nascent molecules in a series of sequential reactions 
(20). 
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The basic catalytic modules of NRPSs contain either condensation (C), 
adenylation (A) or peptidyl carrier protein (PCP) domains (Fig. 1-1A) (21). The A 
domain selects its cognate amino acid and enzymatically generates a stabilized 
aminoacyl adenylate substrate, requiring ATP.  The PCP domain contains an invariant 
serine at the catalytic site that binds a phosphopantotheine cofactor to which the 
adenylated amino acid substrate is transferred and thioesterified, with release of AMP 
(22).  The C domain is located between the A and the PCP domain and catalyzes the 
formation of a new peptide bond by condensation. Sequential reactions of the assembly 
line arrangement of the three domain units ensure the coordinated elongation of the 
peptide product. Subsequently, the linear peptide chain may be cyclized by the action of 
a thioesterase present at the C-terminus of the NRPS (19, 22). Due to this modular 
biochemistry –known as the colinearity rule- the products that are synthesized by NRPS 
can be predicted from the organization of their synthetic modules (23).  Conversely, the 
primary structure of the peptides can also help to identify the orphan gene clusters 
responsible for their synthesis (24).  
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Figure 1- 1. General biosynthetic organization of NRPS and PKS.  
(A) In NRPS systems, the loading module (LM) consists of an A domain that transfers 
the substrate to the PCP domain. The minimal extension module (EM1) contains a C 
domain that catalyzes a new peptide bond between the PCP and the A domain substrates. 
Optional processing domains (EM2) are used to incorporate modifications to the nascent 
molecule. Biosynthesis is terminated by an integral thioesterase (TE) domain. (B) In 
PKS systems, the typical loading module (LM) contains an AT domain that recruits the 
acyl monomer and transfer it to the ACP. In addition to the AT and ACP domains, the 
extension module (EM1) contains a KS domain to perform the Claisen-like 
condensations. As ilustration, a second extension module (EM2) contain other 
modifying enzymes. (C) The hybrid PKS-NRPS systems contain a mix of domains and 
modular organization from PKS and NRPS. Abbreviations are: AT, acyltransferase; 
ACP, acyl carrier protein; KS, ketosynthase; DH, dehydratase; ER, enoyl reductase; KR, 
ketoreductase; TE thioesterase; A, adenylation; PCP, peptidyl carrier protein; C, 
condensation; N-MTN-methyl transferase; E, epimerase. This figure was adapted from 
Weissman et al (2008) (21). 
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Type I polyketide biosynthesis follows the same colinearity rule principle as in 
the biosynthesis of non-ribosomal peptides (24). Mechanistically, polyketide synthetases 
are closely related to NRPS, as both modular systems utilize multiple carriers for 
covalent binding of monomers and growing chains (Fig. 1-1B) (19).  In general, PKS 
contain multiple modules of at least three catalytic domains that act in tandem to modify 
the nascent molecule. A ketosynthase (KS) domain performs the Claisen-like 
condensations, an acyl carrier protein (ACP) domain binds covalently to acyl 
intermediates, and an acyltransferase (AT) domain recruits and transfers the acyl 
monomers to the ACP. The multidomain structure of type I PKSs contrast with type II 
and type III PKSs, which carry each of their catalytic sites on different proteins or are 
homodimeric single-domain proteins, respectively. Type II and type III PKSs are beyond 
the scope of this thesis. For a further review see (25, 26).  
Type I PKSs are present in many species that belong to the taxonomic groups of 
Pseudomonas spp, actino-, cyano- and myxobacteria (27). In particular, a growing class 
of PKSs known as type I trans-Acyl-Transferase Polyketide Synthases (trans-AT PKSs) 
have been found in bacteria during the last decade. Trans-AT PKSs had been overlooked 
in the past since they are rare in actinomycetes, the main source of antibiotics (28). 
However, an increasing number of proteobacteria, myxobacteria and bacilli have been 
found to be the main source of trans-AT PKSs products (29). For instance, some 
Bacillus species produce macrolactin and bacillaene and their enzymatic machineries 
serve as models for trans-AT PKSs (30). 
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Trans-AT PKSs generally deviate from the colinearity rule (23, 31). They are 
characterized by the absence of AT domains in their synthetic modules so that the 
monomers are incorporated by AT enzymes that act in trans (32) (Fig.1-2). In addition, 
Trans-AT PKSs are the product of DNA arrangement mosaics from multiple gene 
segments gained via extensive horizontal gene transfer between bacteria (31). Therefore, 
the architecture of the modules is highly variable and may include repeated domain sets, 
modules split between proteins and apparent superfluous domain that contradict the 
colinearity rule and make it difficult to predict function based on PKS structure (29, 31). 
In consequence, the majority of the efforts in relation with trans-AT PKSs have been 
mainly focused on the prediction of their molecular architectures and synthetic 
mechanisms. The coordinate regulation for the expression of genes that encode the 
synthetic proteins is poorly understood. 
 
Bacillaene, a prototype for trans-AT PKSs 
Bacillaene, a protein synthesis inhibitor, was the first product of a trans-AT 
PKSs to be discovered, in 1993 (33). The whole genome sequencing of B. subtilis strain 
168 established the presence of a PKS but the strain was not able to synthesize its 
product, leading to the conclusion that the pks genes was an evolutionary relic (31). The 
isolation and structure characterization of bacillaene was reported two years later but 
lacked two amino acid building blocks that were predicted from the pks genes, making it  
difficult to predict the relationship between bacillaene and the pks genes (34). The  
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Figure 1- 2. Organization of trans-AT type I PKSs. 
(A) A prototype of type I PKS that contains the AT domain. (B) A trans-AT type I PKS 
lacks the integral AT domain within each module. It may contain a short segment of 
remnant AT residues (green). Abbreviations are: AT, acyltransferase; ACP, acyl carrier 
protein; KS, ketosynthase; KR, ketoreductase (21, 35). 
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connection between the B. subtilis pks genes and the product, bacillaene, was found 
more than a decade later with biological competition assays between B. subtilis str. 
NCIB 3610 and Streptomyces coelicolor and bacillaene structure was confirmed by 
NMR (36, 37). Another independent line of research developed a comparative analysis 
between Bacillus amyloliquefaciens strain FZB42, B. subtilis A1/3 and B. subtilis ATCC 
39320 and found that B. amyloliquefaciens also produce bacillaene (38)(39). Since its 
discovery, the Pks synthetase that produces bacillaene has been a prototype for trans-AT 
PKSs (28). 
The structure of the Pks synthetase and the synthesis of bacillaene have been 
broadly characterized. Bacillaene is a linear molecule and has a high degree of 
conjugation with several cis double bonds (Figure 1-3A). Two main isomers are 
synthesized by the Pks enzymatic complex, bacillaene (C34H49N2O6) and 
dihydrobacillaene (C34H51N2O6), with masses of 581 D and 583 D, respectively. The 
structure of bacillaene allowed a more accurate annotation of the Pks proteins and the 
pks genes (Fig. 1-3B-C). The hybrid PKS/NRPS enzymatic complex contains 13 PKS 
and 3 NRPS modules (PksJ-PksR), three free-standing AT domains (PksCDE) and a 
protein subcluster responsible for a β-methylation in the middle of the hexaene moiety 
(PksCFGHI and AcpK) (36). PksS is a cytochrome P450 homolog that oxidizes 
dihydrobacillaene to bacillaene and PksB is a predicted zinc-dependent hydrolase (40). 
Several other unusual biochemical reactions of trans-AT PKSs are also present in the 
Pks synthetase (31). The first module of PksJ initiates with a α-hydroxy-isocaproic acid 
(α-HIC) as starter unit, instead of the typical acetyl-CoA or malonyl-CoA. There are two  
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Figure 1- 3. Biosynthesis of bacillaene in B. subtilis.  
(A) Structure of bacillaene and dihydrobacillaene. The C14’-C15’ bond is olefinic in 
bacillaene and saturated in the precursor dihydrobacillaene. (B) The pks gene cluster in 
B. subtilis encode the Pks enzymatic complex that produces bacillaene. (C) General 
proposed model for the synthesis of bacillaene.  The two split modules are depicted in 
blue.  In red, the timing of the β- branching by the PksCFGHI/AcpK subcluster. 
Abbreviations: KS, ketosynthase; AT, acyltransferase; T, thiolation; DH, dehydratase; 
KR, ketoreductase; MT, methyltransferase; A, adenylation; C, condensation; ATd, AT-
docking; Hyd, Zn-dependent hydrolase; Ox, flavin mononucleotide-dependent oxidase; 
HCS, HMG-CoA synthase; ECH, enoyl-CoA hydratase/isomerase; TE, thioesterase. 
Adapted from Butcher et al (2008) (36). 
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split modules at PksJ-PksL and PksL-PksM that appear to divide reduction and 
dehydration into discrete steps (36). The timing of the β-branching occurs during 
elongation (as opposed to after), and there is formation of Z double bonds by type A 
dehydrating bimodules (41). The pathway of bacillaene biosynthesis has been elucidated 
to near completion, but little emphasis has been put on the regulation of the pks gene 
cluster nor the function of the molecule. 
 
Relevance of bacillaene in the ecology of B. subtilis 
Antibiotics are not only bacterial weapons for fighting competitors but also 
molecules with multiple functions that may contribute to the stability of entire microbial 
communities (42). Antibiotics were considered for decades to be the microbial deadly 
weapons to kill competitors.  The reason for this misconception is that research on these 
natural compounds has been mainly focused on their role as drugs and not much 
attention has been put on their function in natural environments (43). However, it is 
plausible to think that sub-lethal concentrations of antibiotics are the rule, not the 
exception in nature (44). Indeed, several studies have shown that sub-lethal 
concentrations of antibiotics are intercellular signals to promote the fitness of the 
bacteria that produce them (6, 42, 45).  Bacterial species other than the producers may 
also identify antibiotics as signals to activate biological functions that benefit the entire 
community (42, 46).  However, antibiotics may also be synthesized to compete for space 
and nutrients, although with no lethal effects for the competitors. Non-lethal effects of 
antibiotics, such as developmental arrest or nutrient piracy, would relax the pressure on 
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the competitor to survive and develop resistance (47). Numerous functions have been 
found for antibiotics but a complete understanding of their role in nature still remains to 
be elucidated. These molecules may even have multiple roles in nature and 
understanding these functions is crucial to address the increasing clinical problems of 
antibiotic resistance (14). 
Bacillaene is not only a broad-spectrum antibacterial compound but also a 
molecule with multiple functions, as apparent from competitions assays between B. 
subtilis and Streptomyces spp (37, 48, 49). Bacillaene was first reported as a 
bacteriostatic antibiotic (34). The instability of bacillaene makes it unsuitable as a drug 
but competition assays have revealed the importance of this molecule in the competitive 
fitness of B. subtilis (Fig. 1-4). For example, the growth inhibition effect of bacillaene is 
clearly observed in competition assays pairing B. subtilis with Streptomyces avermitilis 
(Fig. 1-4A). B. subtilis is able to compete with S. avermitilis when bacillaene is present; 
however in its absence (due to a deletion of the pks genes) S. avermitilis inhibits the 
growth of B. subtilis. The interactions of B. subtilis with several other species of 
Streptomyces reveal intriguing phenotypes other than growth inhibition that suggest 
multiple functions of this molecule.  
Competition assays between B. subtilis and Streptomyces coelicolor suggest that 
bacillaene interferes with the secondary metabolism of S. coelicolor. In particular, 
production of undecylprodigiosin (a.k.a. RED) and actinorhodin (a.k.a. BLUE) by S. 
coelicolor seem to be affected in the presence of bacillaene (Figure 1-3B) (37). RED and 
BLUE are two antibiotics whose gene clusters get activated during the transition  
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Figure 1- 4. Absence of bacillaene changes competition outcomes of B. subtilis and 
Streptomyces spp.  
A lawn of 10^5 spores/ml of Streptomyces spp was plated in G7 medium and 2.5 µL of a 
B. subtilis overnight –wild type or ∆pks- was spotted in the middle of the plate. Plates 
were incubated at 30˚C and tracked over time. (A) Bacillaene is an antibacterial 
compound against S. avermitilis. (B) Bacillaene modulates the synthesis of prodiginines, 
RED and BLUE, in S. coelicolor. (C) Bacillaene contributes to the defense mechanisms 
of B. subtilis in competition with S. sp Mg1. 
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between mycelial growth and sporulation (12, 50). During interactions of wild-type B. 
subtilis and S. coelicolor no changes in the synthesis of antibiotics by the latter are 
observed. However, in the absence of bacillaene (B. subtilis ∆pks), the premature 
synthesis of RED and BLUE in the adjacent S. coelicolor becomes apparent (Fig. 1-4B) 
(37). To determine whether bacillaene was affecting the expression of RED and BLUE 
gene clusters, we purified bacillaene and added it to MSgg plates that contained lawns of 
S. coelicolor (10^5 spores/ml). After 24 hours of growth at 30˚C, the plates that 
contained bacillaene had a weak decrease in pigment production (Fig. 1-5A). However, 
qRT-PCR analysis of gene targets from the RED and BLUE gene clusters showed no 
significant differences in the mRNA abundance between bacillaene treated and not 
treated control (Fig. 1-5B). Therefore, bacillaene modulates synthesis of RED and 
BLUE by altering steps in RED and BLUE production that are subsequent to gene 
expression. In addition, three unknown metabolites of m/z 407, 641 and 812 are also 
repressed by bacillaene, as detected by IMS (48). These metabolites are known as 
bacillaene-repressed molecules (BRM) and the mechanism by which they are repressed 
remains to be elucidated.  
Cocultures of B. subtilis with Streptomyces sp. Mg1 highlight the detrimental 
effects of the absence of bacillaene in this competitive interaction (Fig. 1-4C). 
Bacillaene provides a defense mechanism to B. subtilis in competition against S. sp Mg1 
(49). Streptomyces sp. Mg1 causes cellular lysis and disrupts the colony extracellular 
matrix of B. subtilis. Strains of B. subtilis are hypersensitive to the lytic activity when  
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Figure 1- 5. Modulatory effect of bacillaene on production of prodiginines by S. 
coelicolor.  
(A) Bacillaene decreases prodiginine production by S. coelicolor. MSgg plates that 
contained lawns of S. coelicolor (10^5 spores/mL) were incubated at 30˚C after addition 
of bacillaene and tracked over time. Plates that contained bacillaene but not sodium 
phosphate buffer (negative control) decreased the production of bacillaene.  
Susceptibility to bacillaene of S. sp Mg1 ∆s.c. 37 was used as positive control. (B) RNA 
abundance of targets act 1.1, act 2.4 (actinorhodin gene cluster), redD and redL 
(undecylprodigiosin gene cluster) were measured by qRT-PCR. No significant 
differences were found between bacillaene treated and not treated samples. Cq values 
were determined for each target and normalized using Cq for rpoB. Fold-expression 
values reported are relative to the untreated sample for each data set.  
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bacillaene synthesis is disrupted by deletion of the pks operon  (Unpublished work by 
Reed Stubbendieck, Straight lab).  
Bacillaene also seems to arrest the development of aerial hyphae of S. sp. Mg1, 
phenotype known as bald (Fig. 1-6). It has been previously reported that B. subtilis uses 
surfactin to inhibit aerial growth in several Streptomyces spp. (51). Streptomyces sp. 
Mg1 is not sensitive to surfactin due to the production of surfactin hydrolase, an enzyme 
that degrades the molecule (52). Consequently, no bald phenotype is observed when 
surfactin is applied to lawns of Streptomyces sp. Mg1. However, the interaction between 
B. subtilis and S. sp. Mg1 still causes a bald phenotype in the latter, indicating that B. 
subtilis uses alternative mechanisms to inhibit aerial growth in S. sp. Mg1 (51). I have 
concluded that bacillaene arrests aerial growth of S. sp. Mg1 by competition assays 
between S. sp. Mg1 and ∆pks strain (Fig. 1-6A). Lawns of S. sp. Mg1 (10^7 spores/mL) 
in G7 plates with 2.5 µL spots of a ∆pks B. subtilis overnight lost the ability to cause the 
bald phenotype. In addition, direct application of bacillaene to a plate culture is 
sufficient to arrest aerial growth development in S. sp. Mg1 (Fig. 1-6B). Taken together, 
these competition assays indicate the multiple effects of bacillaene on competitor 
streptomycetes. The mechanism(s) of bacillaene action remain to be elucidated.  
 
Regulation of bacillaene production 
In general, synthesis of secondary metabolites by bacteria is regulated at the 
transcriptional level (50, 53–56).  Cells recognize physiological and environmental  
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Figure 1- 6. Bacillaene arrests aerial growth in Streptomyces sp Mg1.  
(A) co-cultures of S. sp. Mg1 and B. subtilis wild type and ∆pks in G7 medium show that 
bacillaene is necessary to cause aerial growth arrestment in S. sp. Mg1. (B) Addition of 
purified bacillaene is sufficient to cause bald phenotype in S. sp. Mg1. 
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signals to activate transcription of genes for secondary metabolites via pathway-specific 
or pleitropic regulators. A pathway-specific regulator is dedicated to control the 
expression of the genes encoding the production of the secondary metabolite. Often the 
regulatory gene is encoded within the gene cluster. A pleiotropic regulator controls 
multiple metabolic functions, one of which may be regulation of the secondary 
metabolite biosynthetic gene cluster. Pleiotropic regulators may exert control on the 
pathway-specific regulator, if present, or directly control the biosynthetic genes. Insights 
on the coordination of those regulatory processes will contribute to a better 
understanding of the regulation of secondary metabolites. 
The regulation and synthesis of bacillaene implies a substantial amount of 
cellular resources (31). The pks gene cluster, which encodes the enzymatic complex that 
produces bacillaene, is one of the earliest AT-less PKS gene clusters to be reported (33). 
The pks genes span almost 80 kb of B. subtilis genome (~2%) and therefore they 
compose the biggest gene cluster in B. subtilis (37). Expression of this massive region of 
DNA has to be precisely controlled such as synthesis of bacillaene does not become a 
burden for the cells.  The pks gene cluster encodes a Pks enzymatic assembly line that 
exceeds 100 nm, being larger than that of the ribosome (31). A single Pks assembly line 
would comprise a core synthetase of nearly 2.5 MD but multiple assembly lines 
assemble into a single organelle-like complex of about 10-100 MD (37). Moreover, 
transcription of the pks genes has to be coordinated with other processes that involve a 
high demand of energy consumption, such as synthesis of flagella for motility and 
formation of spores (57). As an archetype of trans-AT PKS encoding gene cluster, the 
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pks gene cluster contains three ATs (PksCDE) that iteratively load extender units into 
the ACP domains (32, 35, 36). The regulatory mechanisms to activate the pks genes have 
not been elucidated. 
 
Dissertation overview 
The purpose of this dissertation is to investigate the regulatory mechanisms used 
by B. subtilis to control the expression of the pks genes and the production of bacillaene. 
The regulatory proteins involved in the transcriptional activation of the pks genes will be 
discussed in chapter II. The regulatory features present in the pks gene cluster, including 
a novel cis-RNA element that allows the read-through of transcriptional terminators, will 
be discussed in chapter III. The function of the first protein encoded by the pks genes, 
PksA, will be described in chapter IV. Finally, the conclusions and future directions of 
each line of investigation are discussed in chapter V. This dissertation contributes to the 
current knowledge of the ecology of B. subtilis and the activation of biosynthetic 
pathways of natural products. 
In chapter II, I report an intricate network of transcriptional regulators that 
coordinate the expression of the pks genes. I provide evidence that PksA does not 
participate in the regulation of these genes, as it was previously assumed.  Instead, 
transcription of the pks genes requires the coordination of multiple regulatory proteins 
that are also involved in developmental transitions and nutrient stress response. In 
particular, CodY, a stationary-phase global regulator that senses nutrient scarcity, 
induces the highest expression of the pks genes at the entry into stationary phase. A 
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master regulator for development, Spo0A, is also responsible for full induction of the pks 
genes. The intervention of multiple regulators leads to a transient repression of the pks 
genes during motility and their activation during stationary-phase functions, such as 
biofilm and sporulation. With this work I provide a better understanding of cell 
specialization for the biosynthesis of antibiotics. I hypothesize how this knowledge can 
contribute to the fitness of B. subtilis population during bacterial competition. 
Chapter III presents intriguing data about the dynamic regulatory elements along 
the pks genes that allow differential gene expression during vegetative growth and 
sporulation. Promoters upstream of pksB, pksC and pksD are active during vegetative 
growth. The pksC promoter seems to control the expression of almost 77 kb, form pksC 
to pksR. Surprisingly, a promoter at pksG becomes very active during sporulation. This 
activation of gene expression is not only differential respect to the genes upstream of 
pksG but also compartmentalized inside the forespores. The data also suggest that the 
intergenic region between pksC and pksD is a novel cis-RNA element that promote read-
through of termination sites at the pks genes. To my knowledge, no regulatory RNAs 
had been reported to control production of natural products. I speculate about the 
biological functions of the peculiar characteristics of the pks operon. With this work, I 
provide new insights on antibiotic regulation in many organisms that encode 
biosynthetic enzymatic complexes in gene operons with similar organization.   
In chapter IV, I extend my investigation about PksA, the previously presumed 
regulator of the pks genes. In chapter II, I found that PksA is not involved in the control 
of bacillaene production.  In chapter IV, I present evidence that PksA controls the 
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expression of its own gene and ymcC, a gene with unknown function that sits adjacent 
and divergently oriented to pksA. The control exerted by PksA on ymcC is strong and no 
detectable levels of YmcC are observed at any time during vegetative growth. However, 
YmcC is observed during sporulation, suggesting a potential role during spore 
maturation or germination. Possible roles during these stages of development and 
potential experiments to solve these questions are also proposed. 
Last, chapter V contains the general conclusions of this dissertation and discusses 
the future directions of this research. I propose connections between the different 
transcriptional regulators of the pks genes, based in previous and current work. I include 
ideas related with temporal control of the regulatory features of the pks genes to 
optimize the production of bacillaene. I also speculate about the roles of the differential 
activation of pks promoters and the cis-regulatory RNA during cell sporulation.  
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CHAPTER II 
BACTERIAL COMPETITION REVEALS DIFFERENTIAL REGULATION OF 
THE pks GENES BY Bacillus subtilis* 
 
Summary 
Bacillus subtilis is adaptable to many environments in part due to its ability to 
produce a broad range of bioactive compounds. One such compound, bacillaene, is a 
linear polyketide/non-ribosomal peptide produced by B. subtilis. The pks genes encode 
the enzymatic megacomplex that synthesizes bacillaene. The majority of the pks genes 
appear to be organized as a giant operon (> 74kb from pksC-pksR). In previous work, a 
deletion of the pks operon in B. subtilis was found to induce prodiginine production by 
Streptomyces coelicolor. Here, colonies of wild type B. subtilis formed a spreading 
population that induced prodiginine production from Streptomyces lividans, suggesting 
differential regulation of pks genes and thus bacillaene. While the parent colony showed 
widespread induction of pks expression among cells in the population, we found that the 
spreading cells uniformly and transiently repressed the expression of the pks genes. To 
identify regulators that control pks genes, we first determined the pattern of pks gene 
expression in liquid culture. Next we identified mutations in regulatory genes that 
disrupted the wildtype pattern of pks gene expression. We found expression of the pks 
                                                
* This chapter, written by Carol Vargas-Bautista, was adapted from the original publication in Journal of 
Bacteriology (149): Vargas-Bautista C, Rahlwes K, Straight P. 2014. Bacterial Competition Reveals 
Differential Regulation of the pks Genes by Bacillus subtilis. J. Bacteriol. 196:717–28 (Copyright © 
American Society for Microbiology. Reprinted with Permission.) 
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genes requires the master regulator of development, Spo0A, through its repression of 
AbrB, and the stationary-phase regulator, CodY. Deletions of degU, comA, and scoC had 
moderate effects, disrupting the timing and level of pks gene expression. The observed 
patterns of expression suggest that complex regulation of bacillaene and other antibiotics 
optimizes competitive fitness for B. subtilis. 
 
Introduction 
Bacillus subtilis is a globally dispersed bacterial species that is competitive in 
diverse environments and produces numerous bioactive compounds. B. subtilis dedicates 
4-5% of its genome to produce secondary metabolites (19). In particular, three massive 
gene clusters encode enzyme complexes for dedicated synthesis of their cognate 
products. Two of the gene clusters encode the non-ribosomal peptide synthetases 
(NRPS) for surfactin (srfAA-srfAD; 27 kb) and plipastatin (ppsA-ppsE; 37 kb), 
respectively.  Surfactin is a multifunctional lipopeptide that provides surfactant and 
signaling activities required for motility and biofilm development (58–60). Plipastatin is 
a lipopeptide with antifungal properties (61, 62). A third gene cluster (pksA-pksS; 78 kb) 
encodes machinery for the production of bacillaene, a hybrid non-ribosomal 
peptide/polyketide (NRP/PK) produced by B. subtilis (36, 37).  
The diverse functions of bacillaene are apparent from competition studies pairing 
B. subtilis with species of Streptomyces (37, 48, 49) (See chapter I). The importance of 
bacillaene for competitive fitness of B. subtilis raises the question of how the organism 
regulates pks gene expression and bacillaene biosynthesis. The pks gene cluster has been 
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annotated as sixteen genes, five of them encoding the multimodular synthetase (pksJ, L, 
M, N, and R), and another ten (pksB-pksI and pksS) genes encoding individual enzymes 
that function in trans to the assembly line (Fig. 2-1A). The first fifteen genes, pksA-
pksR, are oriented in the forward direction (positive strand) and the last gene, pksS, in 
the reverse direction (negative strand). In many cases, modular type I PKS, NRPS and 
hybrid PKS-NRPS gene clusters include associated regulators that coordinate the 
expression of the synthesis genes (24, 63). The pksA gene sits adjacent to the gene 
cluster and encodes a putative TetR-family regulatory protein 
(http://genolist.pasteur.fr/SubtiList/). PksA is predicted to function as a pathway-specific 
regulator of the pks genes, but the regulatory function has not been experimentally 
confirmed (38–40). In addition to pathway-specific regulation, secondary metabolic 
pathways are commonly controlled by global regulatory functions that respond to 
changes in nutrient conditions or environmental cues to activate different physiological 
responses (17, 55). Differentially regulated functions in B. subtilis include genetic 
competence, motility, biofilm formation, and sporulation, in addition to production of 
antibiotics and degradative enzymes (64). Regulation of developmental processes has 
been studied in detail for B. subtilis, and in many instances the regulatory functions are 
known to influence secondary metabolism (19, 57, 64). Studies of surfactin, bacilysin, 
and other metabolites highlight the integration of secondary metabolism with different 
physiological states (58, 60, 65, 66) 
In the present study, we identified a competitive interaction with S. lividans that 
suggested differential regulation of bacillaene production between morphologically  
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Figure 2- 1. The pks gene cluster in B. subtilis  
(A) Sixteen genes from pksA to pksS (78.6 kb) comprise the pks gene cluster as 
annotated in the B. subtilis 168 genome. Dark gray arrows represent the genes encoding 
the multimodular PKS enzymes that synthesize bacillaene. White arrows represent genes 
encoding functions required in trans to the multimodular enzymes. The black arrow 
represents pksA, which encodes a predicted TetR-family transcriptional regulator. 
Arrows are drawn to scale. (B) Expansion of the genes pksA – pksI and pksS highlights 
the intergenic regions (not to scale). Potential transcriptional control regions are 
indicated with red flags (67).  
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different subpopulations of B. subtilis. We investigated the regulation of pks gene 
transcription to determine whether bacillaene production is segregated in different B. 
subtilis subpopulations. Initially using liquid cultures, we show that the 5’UTR of pksC 
is active in promoting expression of the apparent pks operon, which extends nearly 75kb 
from the pksC to pksR genes (http://subtiwiki.uni-goettingen.de/apps/expression/) (67). 
Also, we show that the gene annotated as pksA does not encode a pathway regulator for 
bacillaene. Using transcriptional reporters fused to the pksC promoter element, we 
identified multiple global regulators that influence expression of the pks genes. We show 
that Spo0A is required to activate pks gene expression through repression of the 
transition state regulator, AbrB (19, 68). Expression of pks genes is also dependent on 
CodY, which regulates metabolism in response to nutrient status and was recently shown 
to bind to multiple sites in the pks operon (69, 70). DegU, ComA and ScoC are also 
required for full induction of pks gene expression. Using transcriptional reporters, we 
show that the expression of pks genes is homogeneously and transiently repressed in 
cells that spread toward S. lividans in a competitive interaction. Our data indicate that B. 
subtilis uses multiple regulatory functions to exert dynamic control of bacillaene 
production, which may benefit the overall competitive fitness of the colony. 
 
Material and methods 
Bacterial strains, primers, media and growth conditions 
Table 2-1 contains a list of strains used in this study. The undomesticated strain 
Bacillus subtilis NCIB 3610 was used for all the experiments in this work. Unless 
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otherwise stated, all B. subtilis strains were cultured at 37°C in CH medium (1% casein 
hydrolysate, 0.47% L-glutamate, 0.16% L-asparagine, 0.12% L-alanine, 1 mM KH2PO4, 
25 mM NH4Cl, 0.22 mg/ml Na2SO4, 0.2 mg/ml NH4NO3, 1 µg/ml FeCl3.6H2O, 25 
mg/liter CaCl2.2H2O, 50 mg/ liter MgSO4, 15 mg/liter MnSO4.H2O, 20 µg/ml L-
tryptophan, pH 7.0), which is commonly used for consistent timing of developmental 
transitions and optimal for live cell microscopy (71). To generate a uniform population 
of cells in early exponential growth phase, overnight cultures of B. subtilis were diluted 
to an OD600 = 0.085, cultured to approximately OD600 = 0.2, and re-diluted to OD600 = 
0.085. This cycle was repeated three times before initiation of the experiments. Genetic 
manipulations of B. subtilis were initially made using the PY79 strain, and then 
transduced via bacteriophage SPP1 into B. subtilis NCIB 3610 as previously described 
(72). All manipulations were confirmed by genomic extraction, amplification of genetic 
targets and sequencing.  Escherichia coli XL1 blue was used for plasmid manipulations 
and storage.  
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Table 2- 1.  Strains used in this study 
 
Strain Relevant Genotype Source 
PSK0531 Streptomyces lividans wild-type strain TK24 Laboratory collection 
PDS0066 B. subtilis NCIB3610 Wild-type Laboratory collection 
PKS0212 B. subtilis NCIB3610 pksR:yfp spec (37) 
PDS0184 B. subtilis NCIB3610 pksA::Kn This study 
PDS0480 B. subtilis NCIB3610 pksA::Kn lacA::pksA (mls) This study 
PDS0183 B. subtilis NCIB3610 ∆pksA amyE::Phyperspac:pksA:lacI (cat) This study 
PDS0032 B. subtilis NCIB3610 amyE:: PpksB-yfp (cat) This study 
PDS0036 B. subtilis NCIB3610 amyE:: PpksC-yfp (cat) This study 
PDS0035 B. subtilis NCIB3610 amyE:: PpksS-yfp (cat) This study 
PDS0189 B. subtilis NCIB3610 amyE:: PpksB-lacZ (cat) This study 
PDS0227 B. subtilis NCIB3610 amyE:: PpksC-lacZ (cat) This study 
PDS0201 B. subtilis NCIB3610 amyE:: PpksS-lacZ (cat) This study 
PDS0430 B. subtilis NCIB3610 amyE::PpksC-yfp (cat) lacA::Phag-cfp (mls) This study 
PDS0432 B. subtilis NCIB3610 amyE::PpksC-yfp (cat) lacA::PtapA-cfp (mls) This study 
PDS0431 B. subtilis NCIB3610 amyE::PpksC-yfp (cat) lacA::PsspB-cfp (mls) This study 
PDS0327 B. subtilis NCIB3610 ∆spo0A::mls This study 
PDS0382 B. subtilis NCIB3610 ∆degU::tet Kolter lab 
PDS0247 B. subtilis NCIB3610 ∆abrB::tet Kolter lab 
PDS0262 B. subtilis NCIB3610 ∆abh::km Kolter lab 
PDS0512 B. subtilis NCIB3610 ∆comA::cat This study 
PDS0368 B. subtilis NCIB3610 ∆scoC::km This study 
PDS0525 B. subtilis NCIB3610 ∆codY::mls This study 
PDS0337 B. subtilis NCIB3610 ∆sigD::mls Kearns Lab 
PDS0311 B. subtilis NCIB3610 ∆spo0A::mls ∆abrB::tet amyE:: PpksC:lacZ (cat) This study 
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Antibiotics used in this study were chloramphenicol (5 µg/ml), spectinomycin (100 
µg/ml), tetracycline (10 µg/mL), kanamycin (10 µg/mL) and mls (1 µg/mL of 
erythromycin, 25 µg/mL of lincomycin).   
 
Co-culture assays   
G7 plates (1.5% Bacto agar, 1% Bacto Malt Extract, 0.4% yeast extract and 0.4% 
D-glucose, buffered with 100 mM morpholinepropanesulfonic acid [MOPS] and 5 mM 
potassium phosphate) were used to co-culture B. subtilis and Streptomyces lividans. X-
gal (300 µg/ml) was added to the plates when needed.  Briefly, 2 µl of S. lividans spores 
(107 spores/ml) were spotted on solid media and incubated at 30°C for 12 hours. 
Following initial incubation of the S. lividans, 1.5 µl aliquots of a B. subtilis overnight 
culture were spotted in a cross-wise pattern to the S. lividans, and plates were returned to 
incubation at 30°C.  Taking as time zero when B. subtilis was spotted, the co-culture was 
observed over time and images were captured at the indicated time points. 
 
Extraction and quantification of bacillaene  
Time course experiments were done in triplicate with cells growing at 30°C, in 
500 ml of CH medium, under constant agitation (250 rpm) and complete darkness. To 
extract bacillaene, 15 ml of the culture supernatants were mixed 1:1 with 
dichloromethane. Bacillaene was recovered by evaporation of the organic phase 
followed by resuspension in methanol. The methanol was then evaporated and the 
samples resuspended in a buffer of 65% 20 mM sodium phosphate/ 35% Acetonitrile 
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and H2O. HPLC analysis was performed with a C18 reverse-phase column 
(Phenomenex). Samples were eluted with a gradient of 35% - 40% acetonitrile and 65% 
- 60% of 20mM sodium phosphate. Bacillaene was detected by UV absorption using a 
wavelength of 361 nm as previously reported (9). The amount of bacillaene in each 
sample was determined by integrating the area under the relevant peaks on the elution 
chromatograph. We confirmed the specificity of bacillaene peaks in the HPLC 
chromatographs by comparison to a sample from a B. subtilis ∆pks strain. LC-MS 
analysis determined that the relevant peaks were all different isoforms of bacillaene (not 
shown). Quantitative data was normalized to the sample cell density (OD600) in order to 
compare synthesis of the molecule over time between strains.  
 
Quantitative RT-PCR (qRT-PCR)   
Cell samples were stabilized using RNAprotect Bacteria Reagent (Qiagen) and 
RNA isolation was performed using RNeasy Mini Kit (Qiagen), according to the 
manufacturer’s instructions. Subsequently, RNA samples were treated with Turbo DNA-
free kit (Applied Biosystems) to remove DNA traces and total RNA was quantified. 
Thermo Scientific DyNAmo Flash SYBR green qPCR kit was used with target specific 
primers listed in Table 2-2 and 200 µg of total RNA as template to synthesize cDNA. 
After the RT step, quantitative PCR was done in a CFX96 Touch Real Time PCR 
thermocycler (BioRad). The protocol was as follows: denaturation at 95.0°C for 15 min; 
39 cycles of denaturation at 94.0°C for 10 s, annealing at 58.0°C for 25 s, extension at 
72.0°C for 30 s; and final melt curve from 60.0°C to 95.0° for 6 min. We determined 
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that gyrB transcript abundance per cell did not significantly change from OD600 = 0.2 to 
6.8 (not shown). Consequently, we used gyrB as the reference gene. The samples were 
run in triplicate for each target gene and negative controls where included for each 
sample as reaction mixtures with total RNA after DNase treatment (no RT performed). 
Primer efficiency and Cq values were calculated using the software LinReg (73). Gene 
study analysis for comparison between independent experiments was performed based 
on the primer efficiency calculated by the software LinReg and the analysis of the CFX 
Manager software (Bio-Rad). 
 
Western blots   
Cell growth conditions are the same as described for extraction and 
quantification of bacillaene (see above).  Fifteen milliliters of cell pellets from each time 
point were lysed by incubation in 500 µl of lysis buffer (50 mM Tris 7.5, 200 mM NaCl, 
0.5 mM EDTA, 5 mM MgCl2, 1mg/ml lysozyme, 1 mM 4-(2-
Aminoethyl)benzenesulfonylfluoride hydrochloride (AEBSF), 1 mM DTT) at 37ºC for 
15 min.  After treatment, protein concentration was measured by Bradford Assay (Bio-
Rad Protein Assay) and lysates were diluted to 1 mg/ml of total protein.  Addition of 2X 
loading buffer in a 1:1 ratio and heating at 100ºC for 5 min was done before loading 30 
µl of the samples in 8% acrylamide gel for SDS-PAGE.  Proteins were transferred onto 
an immobilon PVDF membrane (Sigma). Rabbit anti-GFP (1:1000) and goat anti-rabbit 
HRP (1:5000) (Invitrogen) served as primary and secondary antibody, respectively.  The 
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blotting was visualized using Pierce ECL western blotting substrate (ThermoScientific) 
according to manufacturer instructions. 
 
Fluorescence microscopy   
Samples from shaken liquid cultures in CH medium were taken for fluorescence 
imaging, centrifuged at 8,000 rpm and washed once with PBS.  Cells were resuspended 
in 20 µM 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate 
(TMA) (Molecular Probes) and fluorescence images were captured using a Nikon Ti-E 
inverted microscope equipped with a CFI Plan Apo Lambda DM 100X objective, TI-DH 
Diascopic Illuminator, and a CoolSNAP HQ2 Monochrome Camera. Exposure time was 
2,000 ms for YFP, 200 ms for CFP and 1,000 ms for TMA. The NIS-elements AR 
software was used to capture and process the images identically for comparative 
analysis.   Samples from solid media were scraped, dissolved in PBS, passed repeated 
times through a 25g 1½ needle to disrupt aggregated cells and centrifuged at 8,000 rpm. 
All the subsequent steps were the same as described for samples from liquid medium. 
 
Construction of pksA mutants  
Deletion of pksA was performed by long-flanking homology PCR, using the 
primers pksA KO_P1, pksA KO_P2, pksA KO_P3 and pksA KO_P4 (Table 2-2) to 
amplify the region flanking pksA and the intervening kanamycin cassette (74). To 
overexpress pksA, primer pair pksA-90_FHIII/pksA-90_RSalI were use to amplify pksA. 
The amplified regions were cut with the restriction enzymes HindIII and SalI (NEB) and  
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Table 2- 2.  Primers used in this study 
 
Name Sequence (5’-3’) 
pksA KO_P1 gatggccgcgataaaagtaa 
pksA KO_P2 cctatcacctcaaatggttcgctgcgttgcttctgcaatttgtt 
pksA KO_P3 cgagcgcctacgaggaatttgtatcggcgtggaagatacacgtgag 
pksA KO_P4 aacaccttctatgtaatcattttcg 
pksA compl-F atgcatgctagcatctcgagaacccaaaacgcaatttcac 
pksA compl-R aacgtcccggggagctcatgaattccaagaatcgcttttcgcac 
pksA-90_FHIII taaagcttaatccattcccctcttttc 
pksA-90_RSalI ttaagtcgaccaacaagaatcgcttt 
pA-F(EcoRI) ttagaattcataagcgatcgatatacc 
pA-R(HindIII) taggaagcttagctttattgtaacaagaaa 
pC-F(EcoRI) ttagaattcccattcgataaaggat 
pC-R(HindIII) tatgaagcttgattagtagatgtgtttcac 
rtPCR_pksC_1 aaagccgcatctctttttga 
rtPCR_pksC_2 gcatgaaggaactcctcgaa 
qPCR-pksE1 tacgtgagctggatgcaaag 
qPCR-pksE2 atgcttcgggttttgttcag 
qPCR-pksR-F acagcgtaacggaattttgg 
qPCR-pksR-R ttgattgcccttccttatcg 
gyrB qPCR_F gggcaactcagaagcacggacg 
gyrB qPCR_R gccattcttgctcttgccgcc 
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ligated with T4 ligase (NEB) into pPST001 (amyE::Phyperspac lacI cat amp). The 
plasmid was recovered by transformation into E. coli XL1Blue, transformed into B. 
subtilis PY79 and transduced into PDS0184 (Table 2-1), as previously described (72). 
For pksA complementation, pksA compl-F/pksA compl-R primers (Table 2-2) were used 
to clone the pksA gene with 203 bases of upstream sequence into pDR183 (lacA:: mls 
amp) by enzymatic assembly, as previously described (75).  
 
Transcriptional fusions of pks promoters 
Primer pairs pC-F(EcoRI)/pC-R(HindIII) (Table 2-2), were used to amplify 300-
500 bps upstream of pksA, pksB, pksC and pksS, respectively. The amplified regions 
were cut with the restriction enzymes EcoRI and HindIII (NEB) and ligated with T4 
ligase (NEB) into pCW001 (amyE::yfp cat amp) and pDG1661 (amyE::lacZ cat amp).  
The transformations were performed using E. coli XL1Blue for recovery of the 
plasmids. Subsequent transformation into PY79 and transduction into NCIB 3610 B. 
subtilis strains were performed as previously described (72). Recovered clones were 
grown in CH medium for subsequent analysis by fluorescence microscopy and β-
galactosidase assays.  
 
β-galactosidase assays  
Samples were taken over time and cell density measured at OD600.  β-
galactosidase assays were done as previously described by Miller (1972) (76).  Briefly, 
one ml samples were lysed with Z buffer (60 mM Na2HPO4·7H2O, 40 mM 
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NaH2PO4·H2O, 10 mM KCl, 1mM MgSO4·7H2O) that contained 0.27% BME and 
lysozyme (200 µg/ml) at 30°C for 20 min. Then, serial dilutions of the samples were 
done to find an optimal range for colorimetric detection with ONPG (400 µg) at OD420 
and OD550. The values are reported in Miller Units (MU). 
 
Results 
Co-culture of B. subtilis with Streptomyces lividans suggests that bacillaene synthesis is 
inactive within spreading populations of B. subtilis 
In a previous study, we found that a bacillaene-deficient B. subtilis strain (∆pksB-
R, from this point forward ∆pks) induces the production of red-pigmented prodiginines 
(RED) by S. coelicolor (37, 48). Based on the observed pattern of induction, we 
associate RED with the absence of bacillaene in our co-culture assays. In the present 
study, we plated colonies of S. lividans, which also encodes the RED genes, adjacent to 
wild-type B. subtilis colonies (50). Over the course of 4 days, the B. subtilis colonies 
spread on the plates toward the S. lividans colonies (Fig. 2-2). We observed that the 
RED pigment was induced where the spreading B. subtilis population contacts the 
colonies of S. lividans. The observed RED induction is similar to prior observations  
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Figure 2- 2. Induction of RED pigment by S. lividans is associated with absence of 
bacillaene.  
B. subtilis spotted cross-wise with S. lividans inoculated 12 hours prior from a spore 
suspension. Time zero corresponded to inoculation of B. subtilis. Initially, both species 
formed round colonies. After 21 hours, the B. subtilis colonies begun to migrate toward 
S. lividans. Upon contact with B. subtilis (36-72 hours) S. lividans induced prodiginines 
(RED pigment), which are enhanced with extended incubation (90 hours). No RED 
pigment is detected in the absence of colony contact in the time frame studied. The 
images shown represent the results of multiple experiments done in duplicate.  
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using bacillaene-deficient ∆pks strains cocultured with S. coelicolor. The presence of 
RED suggested the possibility that the spreading cells do not produce bacillaene and 
raised the question whether differential expression of the pks genes occurred in different 
subpopulations of B. subtilis.  
 
Bacillaene production peaks at the onset of stationary phase in liquid culture 
To understand the regulatory functions that control bacillaene production, we 
first used classical growth in liquid culture to follow the pattern of bacillaene synthesis 
and to identify the relevant regulatory elements. In previous work, fluorescence 
microscopy of cells expressing individual Pks proteins fused to yellow fluorescent 
protein (YFP) or cyan fluorescent protein (CFP) revealed that the bacillaene 
megacomplex synthetase accumulates within B. subtilis cells as cultures approach high 
cell density (37). This pattern of megacomplex assembly suggests that regulation of 
bacillaene synthesis is coordinated with cellular growth. To build a comprehensive view 
of bacillaene synthesis, we sought to determine whether pks gene expression and 
bacillaene secretion follow a similar pattern as observed for megacomplex assembly. 
Thus, we monitored bacillaene synthesis, megacomplex formation, and pks gene 
expression in samples taken from a liquid culture of the strain PKS0212, which 
expressed YFP fused to the C-terminal end of the PksR protein (Fig. 2-3) (37). We chose 
to use PksR as a representative of the assembly-line enzymes required for bacillaene 
synthesis because the pksR gene resides at the 3’ end of the nearly 75 kb pks operon, as 
described for the pks gene cluster in the SubtiExpress database  
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Figure 2- 3. Bacillaene production during liquid culture of B. subtilis NCIB 3610. 
Strain PSK0212 (PksR-YFP) was cultured in CH medium (30°C), and sampled over 15 
hours. All quantitative data shown are average values with standard deviations from 
triplicate experiments. (A) Growth curve of PSK0212 and HPLC quantitation of 
bacillaene. Equal culture volumes were sampled for OD600 measurements (circles). 
Bacillaene extracted from cell-free supernatants was quantitated by HPLC (triangles) 
(mAU (λ=361nm)/OD600). Peak bacillaene accumulation per OD600 was detected at 
OD600 = 4.2. (B) Western blot (α-GFP) of PksR-YFP from B. subtilis cell lysates. A 
single PksR-YFP band (indicated with an arrow) was detected at low cell densities, and 
increased in intensity to a maximal level observed between OD600 = 1.8 - 2.7. The signal 
intensity for PksR-YFP decreased at higher cell density and lower molecular mass forms 
appeared, suggesting degradation of PksR. (C) Upper panels- Fluorescence images of 
PksR-YFP (green) in cells stained with TMA (red) to visualize membranes. Lower 
panels- Phase contrast images of cells. PksR-YFP signal intensity and number changed 
with cell density. Maximal intensity was observed at the end of log phase (OD600 = 1.8) 
and was diminished at high cell density (OD600 = 6.4). Scale bar, 3 µM. (D) qRT-PCR of 
representative pks genes. Cq values were determined for pksC, pksE and pksR and 
normalized using Cq for gyrB. Fold-expression values reported are relative to the wild-
type lowest cell density sample (OD600 = 0.2) for each data set. The maximal fold 
expression for each transcript occurred at the OD600 = 1.8 time point. 
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(http://subtiwiki.uni-goettingen.de/apps/expression/) (67). As the final product 
transcribed from the pks operon, we postulated that the accumulation of PksR protein 
approximates the amount of completely assembled enzymatic complexes within the cell. 
B. subtilis PSK0212 cultures growing in CH medium at 30°C were sampled at multiple 
times over 15 hours and monitored using three approaches. First, we used HPLC to 
quantitate bacillaene in the culture supernatant (Fig. 2-3A). Second, we used the PksR-
YFP chimera to monitor the protein accumulation by western blot (Fig. 2-3B) and the 
formation of megacomplex by fluorescence microscopy (Fig. 2-3C) (37). Third, we 
measured the abundance of three transcripts that span the length of the operon, pksC, 
pksE, and pksR by quantitative RT-PCR (qRT-PCR) to determine the pattern of pks gene 
expression (Fig. 2-3D). 
The production of bacillaene by B. subtilis followed a pattern typical of many 
antibiotics produced during the transition from exponential growth to stationary phase 
(19, 22, 77). Bacillaene was not detected by HPLC in cultures of low cell density (< 0.5 
OD600). However, the amount of bacillaene per unit OD600 in the culture broth increased 
over time until the onset of stationary phase (Fig. 2-3A). The transition from exponential 
to stationary phase in CH medium occurred above OD600 ~ 1.5 under the culture 
conditions used. Above this cell density, the increase in detectable bacillaene per unit 
OD600 was pronounced, reaching a peak accumulation at OD600 = 4.2. Upon further 
incubation, the amount of bacillaene/unit OD600 in culture supernatants declined, 
suggesting that active synthesis is diminished as cells progress into stationary phase.  
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We hypothesized that the rate of bacillaene synthesis would change with cell 
density if the megacomplex enzymes underwent assembly and subsequent turnover or 
inactivation during the course of growth. In a prior study, PksR-YFP was found to 
increase with cell density up to an OD600 = 1.7 (37). Here, we extended the cultures to 
OD600 = 6.8 in order to track the protein during stationary phase. We examined the levels 
of PksR-YFP protein in cells taken from the culture at the same time points as the 
samples taken for HPLC (Fig. 2-3A). Equivalent amounts of protein from whole cell 
lysates were probed with an anti-GFP antibody to detect the presence of PksR-YFP.  At 
low culture density, PksR-YFP was below the level of detection, consistent with 
previous results (37). However, a band corresponding to 311 kD, the expected molecular 
mass of the PksR-YFP fusion, was readily detected at OD600 above 0.9, and reached 
peak intensity between OD600 1.8 and 2.7, corresponding to the stationary phase 
transition. A second high molecular mass band became visible from OD600 1.8. This may 
represent a modified form of PksR-YFP. Upon further incubation, PksR appears to be 
processed or degraded, as seen by the diminished signal of higher and lower molecular 
mass bands on the western blot (Fig. 2-3B).  
The diminished PksR-YFP signal is consistent with the enzyme being turned 
over during stationary-phase, which would account for reduced bacillaene production in 
culture. We predicted that the fluorescent signal from PksR-YFP in assembled 
megacomplexes would decline in cultures of stationary phase cells in accord with 
degradation of PksR-YFP. Using the same culture conditions as above, we examined 
cells expressing PksR-YFP by fluorescence microscopy to follow the assembly of 
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megacomplexes and their subsequent disruption. As seen in Figure 2-3C, 
megacomplexes became visible as fluorescent foci within cells grown to intermediate 
cell density (OD600 = 1.8). At higher cell density (OD600 = 6.6), fewer PksR-YFP 
positive cells were observed and the overall intensity of the signal per cell is reduced. 
We counted cells with detectable, punctate YFP signal at each sample point and found 
that cells positive for megacomplexes first increased and then reduced to less than 50% 
of the population at high OD600 (Table 2-3). However, an intense fluorescent signal 
persists for a percentage of the cells at high cell density. Whether these cells actively 
produce bacillaene is unknown. Comparison of bacillaene production in Figure 2-3A 
with the fluorescence signal in figure 2-3C reveals a consistent pattern of megacomplex 
assembly and bacillaene synthesis that peaks during the transition to stationary phase 
and decreases upon continued incubation. 
Antibiotic biosynthesis is commonly regulated by transcriptional activation of the 
biosynthetic gene clusters during transition from exponential to stationary growth phase. 
We next sought to determine if the pks genes are expressed in a pattern similar to the 
pattern of bacillaene production. We selected three open reading frames within the 
apparent pks operon for targeted expression analysis. Two of the genes, pksC and pksE, 
are positioned near the 5’ end of the pks operon (Fig. 2-1A). The third gene we analyzed, 
pksR, is the final ORF before the predicted transcriptional terminator and encodes a 
multimodular  
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Table 2- 3.  Formation of Pks megacomplex as seen by fluorescence microscopya 
 
OD600 Total Cell Countb PksR-YFP Count % PksR-YFP 
0.66 185 17 9 
1.06 357 33 9 
1.39 283 49 17 
1.44 277 57 19 
1.66 326 173 49 
1.84 459 385 81 
3.17 594 415 68 
4.07 183 119 63 
5.26 600 368 61 
6.46 367 157 43 
  
aFresh cells were washed once with PBS, resuspended in 20µM TMA, and observed in 
phase contrast, TMA and yfp, as described in Materials and Methods.   
bNumber of cells per microscopic field.  
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PKS enzyme. To compare their patterns of expression at the beginning and end of the 
apparent operon, equivalent amounts of total RNA were used to measure relative 
amounts of transcripts for pksC, pksE and pksR using qRT-PCR. Here we found that all 
of the pks genes followed the same expression pattern (Fig. 2-3D). The transcripts were 
at the lowest level during exponential growth and peaked near the transition to stationary 
phase (1.8 OD600). Consistent with the bacillaene and PksR-YFP results, pks transcripts 
diminished as cells progressed through stationary phase. This pattern of pks gene 
expression and bacillaene synthesis suggests that the production of bacillaene is tied to 
the levels of pks transcript in the cells. 
 
The TetR-family protein PksA is not involved in bacillaene regulation 
Many loci that encode assembly line enzyme complexes also encode 
transcription factors that control the expression of the biosynthetic genes (24, 54, 78). 
The pksA gene, located adjacent to the pks gene cluster, encodes a putative TetR-family 
regulatory protein that is predicted to function as the associated regulator of the pks 
genes (38–40). To determine whether PksA regulates pks gene expression, we replaced 
the endogenous pksA gene with a kanamycin resistance gene and examined the effect on 
pks gene transcripts. We measured the level of pksC, pksE, and pksR transcripts in the 
wild type and ∆pksA strains during the induction phase of pks gene expression (OD600 
0.2 to 1.8), by qRT-PCR (Fig. 2-4). The transcripts of all three genes increased several-
fold for both wild type and ∆pksA strains as cultures exited log phase (Fig 2-4, OD600 = 
1.8). We complemented the ∆pksA mutation with insertion of the pksA gene at  
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Figure 2- 4. PksA function is unrelated to regulation of bacillaene synthesis.  
qRT-PCR data are presented as described for Figure 2-3, panel D. The pksC, pksE, and 
pksR transcripts measured by qRT-PCR were induced in wild type, ∆pksA and the ∆pksA 
genetically complemented mutant (pksA+) strains. Comparison of low (0.2), mid (0.8) 
and high (1.8) OD600 showed induction during growth. Two-factor analysis of variance 
showed no significant effect of the ∆pksA and pksA+ genetic background on the pks 
genes tested (*p-value > 0.05. **p-value >0.01).  
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the amyE locus. The complemented strain showed a similar pattern of gene expression as 
the ∆pksA and wild-type strains (Fig. 2-4). In addition, the ∆pksA deletion had no 
discernable effect on bacillaene production as determined by HPLC (Appendix I. Fig. 
1A). The absence of a phenotype for ∆pksA does not preclude the function of PksA as a 
repressor of pks gene expression. To determine if overexpression of pksA would repress 
pks gene expression, we introduced an IPTG-inducible copy of pksA into the ∆pksA 
strain and quantitated pksC and pksR transcripts. No significant effect on either pks 
transcript was detected in the pksA overexpression condition, despite a 35-fold elevation 
in abundance of pksA transcript (Appendix I. Fig. 1B). Thus, neither deletion nor 
overexpression of pksA significantly perturbed the induction of the pks genes during 
growth of B. subtilis, leading us to conclude that the target of PksA regulation is not the 
pks operon.  
 
The promoter PpksC controls expression of the pks gene cluster 
Collectively, these data indicate that the regulation of the pks operon is coupled 
to cellular growth by an undetermined mechanism. To identify regulatory functions that 
activate bacillaene production, we generated a reporter for transcriptional activation of 
the pks operon. Based on a previous report of B. subtilis global gene expression, three 
putative upstream regulatory sequences are active within the pks gene cluster: PpksB, 
PpksC, and PpksS (Fig. 2-1B) (http://subtiwiki.uni-goettingen.de/apps/expression/) (67). We 
isolated the 5’UTR of pksC, and fused it to the yfp and lacZ genes for fluorescence and 
β-galactosidase assays, respectively. Both fluorescence microscopy and β-galactosidase  
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Figure 2- 5. Activity of promoters of the pks gene cluster.  
(A) Fluorescence of transcriptional reporter for pksC promoter fused to yfp. Cells 
growing in liquid CH medium at 37°C were taken at indicated culture densities to 
observe activation of the promoters. Images represent several microscopic fields from 
samples of two independent experiments.  TMA-stained membranes - red. Promoter-yfp 
fusions - green. Scale bar = 3 µm. (B) β-galactosidase assay of the PpksC-lacZ strain. The 
pattern of β-galactosidase activity indicates the pksC promoter is activated during the 
transition to stationary phase. Miller units are average from triplicate experiments with 
reported standard deviation. (C) Co-culture of S. lividans and B. subtilis (PpksC-lacZ). G7 
plates (300 µg/ml of X-gal) were inoculated with S. lividans and B. subtilis as described 
in Fig. 2-2. PpksC-lacZ activity was differentially localized between spreading and static 
cells in the colony. S. lividans endogenous β-galactosidase activity results in blue 
colonies. Images represent three independent experiments, each time performed in 
duplicate. 
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assays revealed that the pksC promoter is highly active and induced at the same cell 
density as pksC transcripts, as described above (Fig. 2-5A and 2-5B). Thus the PpksC 
reporter fusions provide a tool to determine patterns of pks gene expression in cultures of 
B. subtilis. 
 
Differential activation of PpksC in colonies and motile subpopulations 
We predicted that if bacillaene synthesis were inactivated in the spreading 
populations, as we hypothesized based on the induction of RED synthesis by S. lividans 
(Fig. 2-2), then PpksC-lacZ activity would be differentially localized between the parent 
colony and the spreading subpopulation. B. subtilis carrying the PpksC-lacZ reporter was 
challenged with S. lividans on plates containing X-gal. As previously described, the B. 
subtilis cells spread toward S. lividans on the agar plate, and PpksC-lacZ was differentially 
activated within the colonies (Fig 2-5C). Endogenous β-galactosidase activity of S. 
lividans produced blue streptomycete colonies and obscured the visibility of RED 
pigment in these assays (79). However, β-galactosidase activity from B. subtilis was co-
incident with the primary colony. As seen in Figure 2-5C, at early time points (24 hours) 
the β-galactosidase activity was absent within the spreading population of cells. These 
results supported the observation that the spreading cells are inactive for bacillaene 
production. Upon further incubation (48 hours), PpksC-lacZ activity increased on the 
interior of the spreading population, but remained repressed at the leading edge where 
contact with S. lividans is initiated. We conclude from these data that the pks operon is 
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likely to be activated by regulatory pathways that at least transiently differentiate highly 
motile from static populations. 
 
Multiple regulatory networks control pks gene expression 
B. subtilis uses a complex network of regulatory proteins to control antibiotic 
production, developmental transitions, and specification of cell fates within a population 
(19, 64, 80). To identify regulatory functions that control pks gene expression, we 
surveyed induction of pks gene expression in several strains carrying gene deletions for 
regulators that control antibiotic production, developmental transitions, or nutrient stress 
response. We used liquid cultures of B. subtilis for standardized comparison of pks 
expression levels between mutant strains. Several strains were compared to wild type for 
levels of pks gene expression (Fig. 2-6). A moderate reduction was observed with ∆degU 
and ∆comA strains, which showed disruption of induced pks gene expression as cells 
transition from exponential to stationary phase (OD600 = 1.8) (Fig 2-6A). In contrast, 
moderate elevation of pksC expression was found for the intermediate sample (OD600 = 
0.9) in the ∆scoC mutant strain, which subsequently failed to reach wild-type levels of 
transcript at high cell density. Reproducibly, the ∆spo0A and ∆codY strains had the 
lowest detectable level of pksC expression compared to wild type, suggesting that pks 
gene expression requires dual activation through CodY and Spo0A. 
Spo0A represses transcription of AbrB, which controls multiple antibiotic 
biosynthesis pathways and other transition state processes in B. subtilis (68, 81–83).  
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Figure 2- 6. Regulatory pathways for pks gene expression.  
(A) Quantitative RT-PCR of pksC in liquid cultures of strains: ∆spo0A, ∆abrB, ∆abh, 
∆comA, ∆degU, ∆scoC and ∆codY. Results of qRT-PCR reported as described for Figure 
2-3, panel D. Induction of pksC expression is reduced in ∆spo0A, ∆comA, ∆degU and 
∆codY strains. The ∆abrB maintains pksC induction. Average values and standard 
deviation from triplicate independent experiments are reported. (B) β-galactosidase 
assay of PpksC-lacZ activity in the single mutants, ∆spo0A, ∆abrB, and the double mutant 
∆spo0A ∆abrB. Cells were cultured in liquid CH medium at 37°C and cellular 
equivalents compared from samples taken at the indicated OD600. Deletion of abrB 
restored PpksC activation to the ∆spo0A strain. Miller units are averaged from triplicate 
experiments with standard deviation reported.  
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However, a ∆abrB strain showed a pks gene expression pattern similar to wild 
type (Fig. 2-6A). Because the ∆spo0A strain disrupted pks gene expression, we tested 
whether ∆spo0A-dependent block to pks expression requires AbrB by determining the 
level of pks gene expression in a ∆spo0A ∆abrB double mutant strain (Fig. 2-6B).  To do 
this, we used the PpksC-lacZ strain in order to accommodate existing markers for strain 
construction. Strains with deletions of the spo0A and abrB genes, individually and in 
combination, were used to quantitate pksC promoter activity by β-galactosidase assay.  
The deletion of abrB in a ∆spo0A background restored promoter activity of pksC at all 
time points. We conclude that pks expression is activated by Spo0A through repression 
of AbrB, a pattern shared by several B. subtilis gene clusters encoding antibiotics (19, 
68).  
 
Heterogeneous PpksC activity in liquid cultures of B. subtilis  
Spo0A and CodY are stationary-phase regulators with functions that intersect 
with DegU, ComA, and ScoC-dependent processes, including transitions between motile 
populations, antibiotic production, extracellular matrix production, and sporulation (66, 
70, 84–87). We generated PpksC-yfp reporter strains that also encode fusions of cfp to 
reporters for motility, extracellular matrix, and sporulation to determine whether the pks 
genes are coordinately controlled by these pleiotropic regulators during the switch 
between static and spreading populations. We used a fusion of the promoter for the hag 
gene (Phag-cfp), which encodes the principal flagellar protein, to indicate δD-dependent 
motile cells (80, 88). A PtapA-cfp fusion was used to indicate biofilm matrix-producing  
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Figure 2- 7. Activation of the pksC promoter coincides with activation of biofilm and 
spore formation.    
Fluorescence imaging of pks activation (amyE::PpksC-yfp) with reporters for motility 
(lacA::Phag-cfp), biofilm matrix production (lacA::PtapA-cfp) and sporulation (lacA::PsspB-
cfp). Cells were cultured in liquid CH medium at 37°C and monitored by fluorescence 
microscopy over time. Images shown were taken at indicated culture densities to observe 
activation of the relevant pathway reporters. Flagellum dependent motile cells showed 
low signal intensity for PpksC-yfp. Cells active for matrix production (PtapA-cfp) and spore 
formation (PsspB-cfp) activated PpksC-yfp. TMA- stained membranes - red. Promoter-cfp 
fusions - blue. Promoter-yfp fusions - green. Scale bar = 3 µm. 
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subpopulations. The tapA gene encodes a component of the biofilm extracellular matrix 
and is dependent on Spo0A repression of AbrB for activation (68, 80, 89). In addition to 
Phag-cfp and PtapA-cfp, we used PsspB-cfp to monitor sporulating cells, which are indicative 
of highly phosphorylated Spo0A and CodY derepression under conditions of nutrient 
depletion (57, 80, 90, 91). Fluorescence microscopy was used to examine promoter 
activities at cell densities associated with induction of the respective pathway-specific 
reporters. As seen in Figure 2-7, the cells within each field show heterogeneous intensity 
of PpksC-yfp fluorescence, suggesting differential pks expression in distinct 
subpopulations of cells in a liquid culture (57). The observed pattern of PpksC-lacZ 
activation suggested that pks gene expression is repressed in motile cells expressing Phag-
cfp. Conversely, cells expressing PtapA-cfp also showed elevated levels of PpksC-yfp. Thus, 
the bacillaene operon appears to be induced in matrix-producing populations and not in 
motile subpopulations when B. subtilis is grown in liquid culture. The observed pattern 
is consistent with a pattern of Spo0A-dependent activation and with the PpksC-lacZ 
expression we have observed on agar plates with S. lividans. Upon starvation at high cell 
density, Spo0A is highly phosphorylated and induces sporulation (92). We examined the 
level of PpksC-yfp fluorescence in strains expressing PsspB-cfp as a marker of sporulation. 
The PpksC-yfp signal was detectable in the majority of cells at high cell density (OD600 = 
4.0). In a percentage of the cells, nascent spores were visible by fluorescence of both 
TMA-stained membranes and the PsspB-cfp reporter (Fig. 2-7). Within the visibly 
sporulating population, PpksC-yfp reporter expression was restricted to the mother cells 
and not in developing spores. These observations are consistent with activation of pks 
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gene expression during the transition from exponential growth to stationary phase, 
processes controlled by the master regulatory protein, Spo0A, and the nutrient status 
regulator, CodY (91, 92). 
 
PpksC is homogeneously repressed upon spreading of B. subtilis colonies 
Based on the observed patterns of PpksC-yfp activation in liquid culture, we asked 
whether pks gene expression on solid surfaces was heterogenous and exclusive to 
biofilm matrix-producing cells but not motile cells. We cultured the Phag-cfp, PpksC-yfp 
and PtapA-cfp, PpksC-yfp strains on agar media with S. lividans (Fig. 2-8). We observed in 
these strains that PpksC-yfp activation was uniformly low in the spreading population and 
high in the parent colony, as was also observed with the PpksC-lacZ reporter. The patterns 
of Phag-cfp and PtapA-cfp expression, on the other hand, were heterogenous within these 
populations. This expression pattern indicated that activation of pks gene expression is 
not co-regulated with matrix production per se, which we inferred from its coincidence 
with PtapA-cfp in liquid cultures. Nor is PpksC-yfp strictly repressed in the Phag-cfp marked 
motile cells. Instead, the level of pks gene expression is largely determined by 
differentiation of the spreading population from a static colony. In an effort to define the 
type of motility observed in these assays, we determined that the spreading population is 
dependent upon both surfactin (∆srfAA) and δD (∆sigD) for motility (Appendix I. Fig. 
S2A). Thus, we think the cells are using swarming motility, which requires δD for 
expression of flagellar genes, to propel themselves toward the S. lividans (72). Colony  
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Figure 2- 8. Differential pks genes expression of spreading and static cells of B. subtilis 
in competition with Streptomyces lividans.  
B. subtilis and S. lividans co-cultures were prepared as described in Fig. 2-2. Following 
36 hours of incubation, cells from the leading edge and primary colony of B. subtilis 
were scraped from the agar and prepared for fluorescence microscopy. (A) A reporter 
strain for pks activation (amyE::PpksC-yfp) and flagellar expression (lacA::Phag-cfp). Low 
levels of PpksC-yfp activity were detected in the spreading population, while PpksC-yfp 
activity was elevated in B. subtilis cells from the primary colony. The spreading 
populations had a subpopulation of cells with high levels of Phag-cfp activity that were 
negative for PpksC-yfp activity. (B) A reporter strain for pks activation (amyE::PpksC-yfp) 
and extracellular matrix (lacA::PtapA-cfp). Lower levels of PpksC-yfp activity were also 
detected in the spreading population, compared to the primary colony. Expression of the 
pks genes occurred broadly into the population and not exclusively into the 
subpopulation of producers of extracellular matrix. TMA- stained membranes - red. 
Promoter-cfp fusions - blue. Promoter-yfp fusions - green. Scale bar = 3 µm.  
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spreading also occurs by spontaneous mutation or targeted disruption of competence and 
DNA metabolism genes (93). We found that the spreading cells in our assays are not 
formed of spontaneous mutants, suggesting that the presence of S. lividans either results 
in swarming motility or directional growth by B. subtilis (Appendix I. Fig. 2B). In either 
case, the expression of the pks genes is minimal upon emergence of the swarming 
population. The pattern of transient repression during motility and activation in the 
parent colony is consistent with complex control of pks gene expression by regulators 
that converge on switching between motility and stationary-phase functions, including 
the energy and extracellular responsiveness of CodY and Spo0A. 
 
Discussion 
Bacillaene is an important determinant of outcomes during interactions between 
B. subtilis and competitor species. Bacillaene is essential for survival in competition 
with the predatory-like species Streptomyces sp. Mg1 (49). Also, the presence or absence 
of bacillaene influences how a competitor responds to B. subtilis, as illustrated by the 
induction of prodiginines (RED) by S. coelicolor and as found in the present study by S. 
lividans (37). The present study directly addressed pks gene regulation and the control of 
bacillaene production by B. subtilis. We took a multistep approach to identify regulatory 
functions that control bacillaene production and considered several existing 
transcriptomic studies that suggest modes of bacillaene regulation (67, 69, 83, 94, 95). 
We first determined that B. subtilis in liquid culture induces transcription of the >74kb 
pks operon as the cells exit exponential growth and transition to stationary phase. As the 
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cultures progressed into stationary phase, the production of bacillaene was diminished. 
The level of pks transcripts decreased during stationary phase culture and the Pks 
megacomplexes were degraded as observed by fluorescence of PksR-YFP. Thus a 
similar pattern in liquid culture of induction and subsequent reduction is apparent for pks 
transcript levels, PksR abundance, and the presence of secreted bacillaene. This pattern 
suggests transcriptional regulation is a primary determinant for bacillaene production, as 
opposed for instance, to activation or deactivation of enzymatic assembly lines. 
The regulation of pks gene transcription was previously assigned to the PksA 
protein, annotated as a TetR-family regulator of pks genes. Our results indicate that 
PksA does not regulate pks gene expression, at least under the experimental conditions 
we tested. Our preliminary data suggests that the function of PksA may be directed 
toward an adjacent, divergently transcribed gene, ymcC (not shown). Related organisms 
such as Bacillus amyloliquefaciens FZB42 also produce bacillaene, encoding the 
enzymatic complex in the bae gene cluster (38). In contrast to B. subtilis, the 
orthologous pksA gene of B. amyloliquefaciens FZB42 is located in a region of the 
chromosome separate from the bae biosynthetic gene cluster, suggesting the protein is 
not a pathway-specific regulator (39). Thus these data support a model for pks gene 
regulation and bacillaene production that relies on global regulatory circuits and not a 
pathway-specific regulator such as PksA. 
Evidence for differential activation of pks gene expression emerged from the 
interaction of B. subtilis with S. lividans, which suggested bacillaene is repressed in 
spreading subpopulations. To understand regulatory processes that control bacillaene 
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production, we focused our attention on regulation of the pks operon that extends from 
pksC to pksR. We identified the 5’UTR of pksC as the control element for induction of 
the pks operon, which is consistent with results from a genome-wide study of B. subtilis 
transcription (67). Using PpksC-yfp and PpksC-lacZ reporters, we confirmed that pks gene 
expression was transiently repressed in populations of cells that migrate across agar 
toward S. lividans. We have shown that bacillaene production is principally under the 
control of the Spo0A and CodY stationary phase regulators. However, full induction of 
pks gene expression is also dependent on DegU, ComA, and ScoC, suggesting that B. 
subtilis uses multiple mechanisms to integrate bacillaene synthesis with other cellular 
functions (64, 96–98). The observed patterns of pks gene expression suggest that B. 
subtilis activates and represses bacillaene production in response to nutrient conditions 
and developmental transitions. Similar observations for regulation of several B. subtilis 
antibiotics in liquid culture have been described (19, 60, 65, 66, 68, 72, 99–101) 
Our results support a model wherein B. subtilis inactivates bacillaene production 
during a motile phase induced by growth in the presence of S. lividans. The parent 
colony actively expresses the pks genes. The swarming population initially repressed pks 
expression, which over time becomes active within the motile populations. The 
described pattern of synthesis is consistent with the observation that Spo0A, which 
controls a switch between motile and biofilm matrix-producing cells, are required for 
full induction of the pks genes (80). Additionally, the loss of pks gene expression in the 
∆codY strain revealed that the pks operon is one of a few targets dependent upon CodY 
for expression (102). CodY binds directly to GTP and branched-chain amino acids 
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(BCAAs) as a mechanism for sensing nutrient-rich conditions (91, 103). When bound to 
these signals, CodY represses functions that include motility (e.g. hag and fla-che) and 
antibiotic production (e.g. surfactin and bacilysin) through increased affinity for their 
regulatory DNA elements (87, 104). The ∆codY phenotype for pks gene expression 
suggests that the pks operon is tuned to changes in nutrient availability, and is repressed 
when cells divert resources to motility. We speculate that maintaining low pks gene 
expression in motile populations may be important for energy resource allocation in B. 
subtilis, because synthesis of megacomplexes and bacillaene are likely to require 
considerable energy input. 
Our results suggest a hypothesis that dual regulation of pks expression may 
ensure bacillaene production in high cell-density populations, such as biofilms (Spo0A-
dependent), and under conditions of nutrient availability that permit pks genes 
expression (CodY). In addition, secondary control mechanisms may fine tune expression 
in response to external and internal conditions or signals through DegU, ComA, and 
ScoC. For example, DegU is induced by the presence of glucose through catabolite 
regulator function (105). Thus, a DegU-dependent timing mechanism may exist for 
initial repression by dephospho-DegU, followed by activation through DegU 
phosphorylation and inhibition of motility (106). ComA and ScoC also function in both 
motility control and secondary metabolism. ComA regulates surfactin production, which 
is required for swarming motility, and DegQ, which enhances DegU phosphorylation 
(95, 107). ScoC, which directly controls bacilysin production, also controls the transition 
between motile and biofilm-forming populations through its regulation of flgM and sinI, 
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respectively (66, 98, 108). Thus, ScoC may coordinate the timing of induction for pks 
gene expression, which we found is activated early in a ∆scoC mutant strain. Other, 
unidentified regulatory functions may contribute to pks control as well. How the relative 
timing of interactions between regulatory pathways integrates downstream functions is 
complex and incompletely understood.  
Exploring the divergent functions in static and motile populations of competing 
bacteria provides an experimental system to better understand pathway integration. 
Based on our results, synthesis of bacillaene enters a growing list of processes that are 
divided among subpopulations of clonal B. subtilis cells (109). Regulatory mechanisms 
for antibiotic biosynthesis have been generally studied by culturing bacteria in liquid and 
following patterns of synthesis correlated with cell density. As we have shown, the 
production of bacillaene in liquid culture fits a pattern typical of many antibiotics, i.e. 
induction upon transition out of logarithmic growth. Historically, this timing defines 
antibiotic production within the idiophase (3). When grown on solid surfaces, patterns of 
differentiation suggest that many bacteria have sophisticated mechanisms for 
determining the timing of pathway activation (80). Antibiotic biosynthesis is no 
exception. Developmental regulatory processes also control antibiotic biosynthesis (19). 
For example, many Streptomyces species couple antibiotic biosynthesis with 
developmental pathways of aerial growth and sporulation through complex regulatory 
circuits (17). In some cases, antibiotic biosynthesis is activated by pathway specific 
regulatory genes that may be directed by developmental regulators (27). When no 
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pathway specific regulatory proteins are present, identifying the specific determinants of 
activation requires understanding the developmental control networks of the organism. 
Studies of antibiotic regulation under competition suggest that coordinated 
control of multiple antibiotics with developmental transitions serves to optimize the 
competitive fitness of B. subtilis by ensuring efficient resource allocation (110). The 
convergence of bacterial developmental regulation with control of antibiotic synthesis 
may highlight new approaches to activate or optimize production of molecules of 
interest (111). For example, strategic genetic manipulations of the producing species 
could be used to restrict the organism to a high antibiotic output state, which may also be 
an effective approach to activate cryptic secondary metabolic pathways (112). Future 
examination of developmental controls for antibiotic biosynthesis will likely inform key 
principles of bacterial competition as well as new strategies to induce antibiotic 
production from microorganisms. 
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CHAPTER III 
REGULATORY FEATURES OF THE pks GENE CLUSTER 
 
Summary 
Gene operons are common in bacteria to coordinate the expression of multiple 
genes that participate in a similar metabolic pathway or other concerted processes. In 
addition to regulatory proteins that initiate the transcription, numerous regulatory 
elements are usually present along the operons to elongate transcription of the distal 
genes. The pks genes, from pksB to pksR, span nearly 76 kb and form the largest operon 
in the B. subtilis genome. Several promoters and transcription termination sites along the 
pks genes have been predicted but not tested. In this chapter, we present evidence about 
the activity of the putative promoters upstream of pksB, pksC and pksS (PpksB, PpksC and 
PpksS). Our data suggest that PpksC is the most active promoter and likely controls the 
expression from pksC to pksR (~75 kb) during vegetative growth. A promoter candidate 
at the intergenic region between pksC and pksD did not show any activity. Instead, our 
results indicate that the pksC to pksD intergenic region is a novel cis-RNA element that 
promotes read-through of terminations sites in the pks genes. This a novel mechanism of 
genetic control not previously reported for a natural product encoding gene cluster. Our 
results serve as a model for antibiotic regulation in many organisms with similar long 
operons. We also report the activation of an internal promoter at pksG (PpksG) during 
sporulation that suggests differential pks gene expression at this developmental stage. 
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Introduction 
Gene expression requires a series of concerted regulatory activities at different 
levels of transcription. Regulatory proteins that either block or modulate RNA 
polymerase activity are only the first step of the control of gene transcription 
(113)(Chapter II). In addition, the RNA polymerase must recognize regulatory elements 
in the chromosome, called promoters, to initiate transcription (114). Elongation of 
transcription is accomplished by either the recruitment of elongation factors or 
antitermination systems that promote read-through at transcription termination sites 
(115). Finally, cells stop transcription by two different mechanisms, Rho-dependent 
termination and Rho-independent termination. In a Rho-dependent termination 
mechanism, a protein called Rho destabilizes the complex formed by the RNA 
polymerase and the DNA template. In a Rho-independent termination, also known as 
intrinsic termination, a G-C-rich hairpin loop precedes a poly-U stretch in the nascent 
RNA transcript and forms a mechanical stress that pulls the poly-U stretch out of the 
RNA polymerase active site (116, 117). Intrinsic terminator hairpins (Rho-independent 
terminators) are the predominant mechanism of transcription termination in B. subtilis 
and other Firmicutes (67, 118). Additional genetic features such as operators and 
enhancers may also contribute to regulation of gene expression. 
Bacterial operons are organized to coordinate simultaneous expression of several 
genes through multiple overlapping genetic controls (119, 120). Operons are composed 
of two or more open reading frames that are transcribed as a single mRNA, spanning 
from a few up to several hundreds of kilobases (114). Due to the length of many of these 
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operons, numerous regulatory strategies are necessary beyond transcription initiation to 
extend the expression of every gene of the operon (121). Transcription of the operon 
genes usually initiates at a promoter upstream of the proximal gene of the operon. Then, 
other regulatory sequences along the operon may have auxiliary roles in transcribing 
distal genes. For example, internal promoters are usually present along the operon to 
contribute to increase levels of particular distant genes (122). Cis- acting regulatory 
RNAs may also serve as regulatory elements to induce transcription of entire operons 
(120). 
It is estimated that 4.1% of B. subtilis genes are controlled, at least in part, by 
RNA-mediated genetic control strategies (121). Cis-non-coding small RNAs located at 
the 5’ end or within intergenic regions of long operons may adopt structural 
configurations that affect transcriptional and post-transcriptional regulation (123). Most 
often, these cis- acting regulatory RNAs may affect access to ribosome binding sites, 
mRNA stability or transcription termination signals (124). Cis- RNA elements may 
control intrinsic transcription termination by promoting the read-through of termination 
sites, also known as processive antitermination ((120) and references within). One 
example of these antitermination systems is the EAR element located at the intergenic 
region of the eps operon in B. subtilis (120). The eps operon encodes the synthesis of 
exopolysaccharides required for biofilm formation and it spans nearly 16 kb. The EAR 
element is located in the intergenic region between epsB and epsC and provides read-
through of distally located termination sites to ensure the synthesis of the entire eps 
transcript (120).  
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The pks genes, from pksC to pksR, span nearly 75 kb and form the largest operon 
in the B. subtilis genome. Predictive bioinformatic analysis of the pks gene cluster 
reveals several candidate regulatory elements of the operon (Fig. 3-1). The Subtiexpress 
database reports upshifts in transcription at pksB, pksC and pksS, suggesting the presence 
of promoter elements in these intergenic regions (http://subtiwiki.uni-
goettingen.de/apps/expression/) (Chapter II).  Additional promoters are predicted by 
Subtilist at the intergenic region of pksC and pksD, and in the overlapping region 
between pksF and pksG open reading frames (http://genolist.pasteur.fr/SubtiList/). 
Subtilist also predicts a transcription termination site upstream of pksG. The regulatory 
element organization described in Subtiexpress suggests that the pks genes are organized 
in a single operom from pksC and pksR. In contrast, Subtilist predicts one operon from 
pksC to pksF, and a second operon from pksG to pksR. The presence of these putative 
pks regulatory elements suggests that the control of pks gene expression is complex. 
None of the predicted regulatory elements have been investigated prior to this work. 
In chapter II, we investigated the regulatory proteins that coordinate the initiation 
of transcription of the pks genes at the entry into stationary phase. The question of which 
regulatory elements determine the length of the pks transcript remains to be elucidated. 
In this chapter, we investigate the regulatory features present in the pks gene cluster and 
their role in the expression of the pks genes. In agreement with the predictions, we have 
found that the regions upstream pksB, pksC and pksS are active promoters during 
vegetative growth that contribute to the independent expression of pksB and pksS, 
respectively. Instead, pksC promoter appears to control the expression of the genes from  
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Figure 3- 1. Predicted promoters and terminators of the pks gene cluster in B. subtilis.   
The pks genes from pksB-pksR are about 76 kb long, as annotated in the B. subtilis str. 
168 genome. pksA has been removed from the illustration as our data indicates that PksA 
has no role in the synthesis of bacillaene. Above, arrows are drawn to scale. Below, there 
is a magnification of the genes where additional features are predicted (Not to scale).  
Red flags indicate predicted promoters according to Subtiexpress database 
(http://subtiwiki.uni-goettingen.de/apps/expression/). Green flags indicate additional 
promoters predicted by Subtilist (http://genolist.pasteur.fr/SubtiList/). The feature in blue 
is predicted by Subtilist as a transcriptional terminator upstream of the end of pksF.  
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pksC to pksR. We also found that pksG promoter is highly active in sporulating but not 
vegetative cells, suggesting differential pks gene expression during sporulation. Also, 
our data indicates that the predicted termination site upstream of pksG does not stop 
transcription elongation, at least under the conditions tested. However, abundance of the 
specific transcript between pksF and pksG was low and multiple non-specific bands 
were present, suggesting that the predicted termination site upstream of pksG produce 
some level of transcription interference. We also report what appears to be a novel cis-
regulatory RNA located at the intergenic region between pksC and pksD that promotes 
processive antitermination of the pks operon.    
 
Material and methods 
Bacterial strains, primers, media and growth conditions  
All the experiments of this study were performed with the undomesticated strain 
Bacillus subtilis NCIB 3610. Table 3-1 contains a complete list of the strains used in this 
work. Transcriptional reporters PpksB-yfp, PpksD-yfp, PpksG-yfp, and PpksS-yfp were 
constructed as described in chapter II for PpksC-yfp, using the primer pairs pB-
F(EcoRI)/pB-R(HindIII), pD-F(EcoRI)/pD-R(HindIII), pG-F(EcoRI)/pG-R(HindIII) and 
pS-F(EcoRI)/pS-R(HindIII), respectively (Table 3-2). CH medium was used for 
vegetative growth and 37°C was the default temperature, unless otherwise stated. 
 
Fluorescence microscopy 
Samples from shaken liquid cultures were taken for fluorescence imaging, 
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Table 3- 1. B. subtilis strains used in this study 
 
Strain Relevant Genotype  Source 
PDS0066 B. subtilis 3610  wild type Laboratory collection 
PDS0067 B. subtilis 3610 ∆pksB-R Laboratory collection 
DS7817 B. subtilis 3610 wild type Winkler Lab 
GEE5174 B. subtilis 3610 ∆pksC-D IR Winkler Lab 
GEE5175 B. subtilis 3610 pksC-D IR:: EAR Winkler Lab 
 
PDS0525 B. subtilis 3610 ∆codY Laboratory collection 
PSK0209 B. subtilis 3610  pksE-cfp Laboratory collection 
PDS0032 B. subtilis NCIB3610 amyE:: PpksB-yfp (cat) Laboratory collection 
PDS0036 B. subtilis NCIB3610 amyE:: PpksC-yfp (cat) Laboratory collection 
PDS0204 B. subtilis NCIB3610 amyE:: PpksD-yfp (cat) Laboratory collection 
PDS0207 B. subtilis NCIB3610 amyE:: PpksG-yfp (cat) Laboratory collection 
PDS0035 B. subtilis NCIB3610 amyE:: PpksS-yfp (cat) Laboratory collection 
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Table 3- 2. Primers used in this study 
 
 
Name Sequence (5’-3’) 
pB-F(EcoRI) ctagaattcctgagagactttacgc 
pB-R(HindIII) attcaagcttatcatgtaaagttcttaaac 
PpksD_RI_F atgaattcaccacatccagagcacca 
PpksD_HIII_R gaataagcttcccatgtgatagtatt 
PpksG_RI_F atgaattcatcaaaaatgcgctgagc 
PpksG_HIII_R gaataagcttccggattcagagcaag 
pS-F(EcoRI) aatgaattcgcgctaatagggtaaataga 
pS-R(HindIII) tataaagcttgctatacgcagtacgaatc 
qPCR-pksR-F acagcgtaacggaattttgg 
qPCR-pksR-R ttgattgcccttccttatcg 
gyrB qPCR_F gggcaactcagaagcacggacg 
gyrB qPCR_R gccattcttgctcttgccgcc 
eRT-pksJ-R agtcctagtcgcagaccacgg tcctgatgcatcccccggtcc 
eRT-pksI-F cggcaatgcagggccatgga 
eRT-pksH-F tcagtcgtgcgaaagccaccg 
eRT-pksG-F ggtctcaaccgcaactgccgt 
eRT-pksF-F cttcctcgctgctgtccggc 
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centrifuged at 8,000 rpm and washed once with PBS.  Cells were resuspended in 20 µM  
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA) 
(Molecular Probes) and fluorescence images were captured using a Nikon Ti-E inverted 
microscope equipped with a CFI Plan Apo Lambda DM 100X objective, TI-DH 
Diascopic Illuminator, and a CoolSNAP HQ2 Monochrome Camera. Exposure time was 
1,000 ms for TMA and 2000 ms for YFP. The NIS-elements AR software was used to 
capture and process the images for comparative analysis.   Pseudocoloring within a 
range of 600-4600 LUTs was applied to YFP (green) images for PpksB-yfp, PpksD-yfp, 
PpksG-yfp, and PpksS-yfp. However, due to the intensity of the PpksC-yfp signal, the range 
applied for this promoter was from 600-16000 LUTs. 
 
Induction of sporulation 
Cells growing in CH medium were taken at early exponential phase (OD600 = 
0.5-0.8), centrifuged and resuspended in warm sporulation medium as described by 
Sterlini and Mandelstam (125). The initiation of sporulation was designated as S0, the 
time of resuspension. Samples were harvested at hourly intervals for eight hours (S0-
S7). 
 
Germination and outgrowth efficiency 
B. subtilis strains were induced to sporulate in DSM plates for 48 h at 37°C and 
then collected and treated with lysozyme to eliminate vegetative cells, as previously 
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described (71). The purity of the spore collection was 98% as evaluated by phase-
contrast microscopy. Spores were heat-activated at 80˚C for 20 min, put on ice for 20 
min and incubated at 37˚C in LB broth (initial OD600 = 0.3). Optical density (OD600) was 
measured every five minutes during germination and every ten minutes during 
outgrowth. Each experiment was done in triplicates. 
 
Quantification of bacillaene 
Production of bacillaene was determined as described in Chapter II.  Briefly, 
three early exponential growth cycles were done to generate a uniform population before 
the beginning of the experiment. Then, cell cultures were grown in CH medium, at 30°C, 
constant agitation (250 rpm) and complete darkness.  Samples of 50 ml were taken at 
OD600 of approximately 2.8 and OD600 of approximately 4.5. Supernatants of the 
samples were used to extract and quantify bacillaene. Multiple peaks in the HPLC 
chromatograms represent isoforms of bacillaene that come at different elution times. As 
indicated in Chapter II, LC-MS analysis has confirmed that the relevant peaks are all 
different isoforms of bacillaene. The amount of bacillaene in each sample is determined 
by integrating the area under the relevant peaks on the elution chromatograph. This 
experiment was done in duplicates and repeated two independent times 
 
Exact RT-PCR 
 Cells growing in CH medium were taken at mid exponential growth and 
stabilized using RNAprotect Bacteria Reagent (Qiagen). RNA isolation was performed 
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using RNeasy Mini Kit, according to the manufacturer’s instructions. In this 
modification of RT-PCR, DNase treatment is not necessary due to the use of a hybrid 
primer (pksJ-R) to synthesize cDNA (126). Total RNA (100 ng) was used to perform 
cDNA synthesis with the pkJ-R hybrid- primer (Table 3-2) and using the ProtoScript 
AMV LongAmp Taq RT-PCR Kit (NEB). Negative controls were included (No reverse 
transcriptase) to examine the DNA contamination in the samples Downstream PCR 
amplification was performed with the cDNA product (1/10 of PCR reaction volume) and 
specific primers that annealed several hundreds bp upstream of pksJ (eRT-pksI-F, eRT-
pksH-F, eRT-pksG-F and eRT-pksF-F), as indicated in Table 3-2. The PCR protocol was 
as follows: denaturation at 95.0°C for 30 s; 30 cycles of denaturation at 94.0°C for 15 s, 
annealing at 57.0°C for 30 s, extension at 72.0°C for 50 s/kb; and a final hold at 4.0°. 
PCR amplifications were observed in 0.8% agarose gels. 
 
Quantitative RT-PCR (qRT-PCR)   
RNA isolation, DNase treatment, cDNA synthesis and quantification of transcript 
abundance were performed as described in Chapter II, using the primer pairs listed in 
Table 3-2 (qPCR-pksR-F/qPCR-pksR-R, gyrB qPCR_F/gyrB qPCR_R). Specifically, to 
determine the pksH transcript abundance, wild type cells were grown in CH medium and 
induced to sporulate by resuspension in starvation medium at 37˚C.  Samples were taken 
every hour for 8 hour, from the time of resuspension (S0 – S7) and processed for pksH 
mRNA quantification. To determine the functionality of pksF termination site, cells of 
the strains PSK0209 (B. subtilis pksE-cfp) and PDS0066 (wild type) were grown in LB 
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broth and allowed to reach exponential growth. Then cultures were induced for four 
hours with 1.0 mM IPTG. A control with no IPTG was also used during this experiment. 
The experiments were done in triplicates, two independent times. 
 
Results 
Promoters of the pks operon 
The SubtiExpress database and our own data suggested that the region upstream 
of pksC act as an active promoter in the pks gene expression (http://subtiwiki.uni-
goettingen.de/apps/expression/) (See Chapter II). However, other transcriptional 
initiation regions have been predicted to exist in the pks gene cluster. As mentioned, 
SubtiExpress database shows three expression upshifts or promoters within the pks 
genes, namely, PpksB, PpksC, and PpksS (Fig. 3-1) (http://subtiwiki.uni-
goettingen.de/apps/expression/) (67). In addition, Subtilist database also predicts one 
region with -35 and -10 signals upstream of pksD, and one region with a -35 signal 
located 5 bp upstream of pksG and a -10 signal located 13 bp downstream of the 
initiation codon of the pksG open reading frame (http://genolist.pasteur.fr/SubtiList/). 
Therefore, in addition to the pksC promoter (PpksC) studied in chapter II, we isolated the 
5’UTRs of pksB (PpksB), pksD (PpksD), pksG (PpksG) and pksS (PpksS) and fused them to yfp 
for fluorescence microscopy. To determine the activity of these predicted promoters at 
different stages of growth, we obtained samples at mid (OD600 ~ 0.8), late exponential 
growth (OD600 ~ 1.8) and stationary phase (OD600 ~3.0), and observed them under the 
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fluorescence microscope (Fig. 3-2A).  Fluorescence signal from PpksD was not detected at 
any time point studied during this experiment. Low fluorescence signal was detected 
from PpksB and PpksS at mid exponential growth but the signal increased as the cells 
reached stationary phase, suggesting PpksB and PpksS are involved in activation of the pks 
genes. Consistent with our previous results, PpksC had the strongest fluorescence signal at 
all observed time points, indicating that PpksC is the most active promoter in the pks 
operon. To our surprise, PpksG fluorescence signal was not observed at any time during 
vegetative growth but a strong signal was observed inside the forespores at stationary 
phase. The strong signal of PpksG suggests that high expression of genes downstream of 
this promoter is occurring during spore formation.  In summary, our data suggest that 
PpksB, PpksC and PpksS are active promoters of the pks operon and reach a peak of activity 
at the entry into stationary phase. PpksG, is active only during sporulation and its activity 
seems to be exclusive to the forespore but not the mother cells.   
The intriguing results of the pksG promoter prompted us to determine the 
sporulation stage at which PpksG becomes active. We induced spore formation by 
resuspending in starvation medium a culture of the PpksG-yfp strain in mid-exponential 
growth. We tracked the stages of spore formation by fluorescence microscopy (Fig. 3-
2B). As expected, asymmetric division and formation of polar septa occurred at S1.  
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Figure 3-2. Activity of promoters of the pks gene cluster.  
Fluorescence signal was analyzed as described in methods and Fig. 2-2. Images 
represent several microscopic fields from samples of three independent experiments.  
TMA -stained membranes - red. Promoter-yfp fusions - green. Scale bar = 3 µm. (A) 
Fluorescence of transcriptional reporters for promoters upstream of pksB (PpksB), pksC 
(PpksC), pksD (PpksD), pksG (PpksG) and pksS (PpksS) were fused to yfp. Cells growing in 
liquid CH medium at 37°C were taken at indicated time points to observe activation of 
the promoters. PpksB, PpksC and PpksS showed fluorescence signal at all times. PpksG 
fluorescence signal was observed inside forespores at late stationary phase. PpksD 
fluorescence signal was not observed at any time. (B) Fluorescence of PpksG during spore 
formation. Spore formation was induced by resuspension of exponential growing cells in 
Resuspension Medium. Samples for fluorescence microscopy were taken hourly from S0 
– S7.  PpksG is active in the majority of forespore-forming cells at S2. (C) Abundance of 
pksH mRNA as measured by qRT-PCR. Wild type cells were induced to sporulate as 
described in Material and Methods.  Fold-expression values reported are relative to S0. 
The maximal fold expression occurred at S2 and then expression rapidly decreased.  The 
experiment was done in triplicates, at two independent times. 
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PpksG became highly active soon after formation of polar septum, and PpksG-yfp signal 
remained strong at all stages of sporulation. Given that at late sporulation stages the 
forespores are already entering dormancy, we suspected that the strong yfp signal at the 
latest stages of sporulation could be caused by the absence of degradation of yfp rather 
than activity of PpksG. Using qRT-PCR, we detected that the abundance of the pksH 
transcript reached a 25-fold increase at S1 but rapidlly decreases over the subsequent 
phases of sporulation (S2-S7) (Fig. 3-2C). Taken together, these results suggest that 
compartmentalization of pksG downstream gene expression occurs at early stages of 
spore formation.  
The PpksG activation during sporulation is suggestive of a function for bacillaene 
during either sporulation or germination. In an attempt to determine whether bacillaene 
is essential for B. subtilis spore formation, germination or outgrowth, we investigated the 
efficiency of sporulation and germination of a ∆pks mutant (Fig. 3-3). First, we induced 
sporulation of the strains by resuspension in starvation medium, as described above. 
Formation of polar septum and development of spores was similar in the wild-type and 
the ∆pks strains, as observed by phase-contrast microscopy (Fig. 3-3). Heat-resistant 
spores were also counted on LB agar plates after overnight incubation in starvation 
medium. No differences in the number of spores that initiated vegetative growth was 
found (data not shown). Second, to determine the efficiency of germination and 
outgrowth, spores suspension of wild-type and ∆pks strains were incubated in LB broth 
at 37˚C and OD600 was measured over time (Fig. 3-4). No significant differences were  
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Figure 3- 2. B. subtilis sporulation in a ∆pks mutant.  
Fluorescence microscopy of wild-type and ∆pks strains during sporulation.  Induction of 
spores was performed as indicated in Figure 3-2B and methods.  Formation of polar 
septum is observed at the expected stages for both, wild type and ∆pks strains (red arrow 
heads).  
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Figure 3- 3. B. subtilis germination and outgrowth in a ∆pks mutant. 
(A) B. subtilis germination. The y-axis represents the outgrowth as % of OD600 loss 
given that the optical density decreases during the outgrowth.  No significant differences 
are found in wild type and ∆pks outgrowth (B) B. subtilis outgrowth in LB medium. 
Wild type and ∆pks spores were transferred to LB medium and incubated at 37˚C. OD600 
was measured every five minutes during outgrowth and 10 minutes during germination.  
Changes in OD600 were similar in both, wild type and ∆pks strain.  
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found in B. subtilis germination and outgrowth between wild type and the ∆pks mutant 
under the conditions tested. Therefore, the role of bacillaene and the differential 
promoter activation of the pks genes downstream of pksG remain to be elucidated. 
 
Transcription termination site at pksF  
Transcription termination sites are sequence elements necessary to mark the end 
of single coding sequences and operons. According to Subtilist, the pks genes span 
almost 75 kb from pksC to pksR, in the positive strand, with a single intrinsic termination 
site before the end of the pksF locus and a bidirectional terminator between pksR and 
divergently transcribed pksS. (http://genolist.pasteur.fr/SubtiList/) (Fig. 3-1 and Table 3-
3). To visualize whether a transcript truncation occurs at the end of pksF, we conducted 
an Exact RT-PCR analysis from pksF to pksJ. We predicted that if transcription 
termination occurs at pksF we would detect transcripts from pksG to pksJ but no 
transcript would be observed from pksF-pksJ. As shown in Figure 3-5A, single 
amplification products ranging from pksG to pksJ were observed at the expected sizes. 
However, amplification from pksF to pksJ at the expected size (4.4 kb) was not 
observed, and multiple non-specific bands were visible. In the absence of reverse 
transcriptase (negative controls) no PCR products were observed (data not shown).  
These results suggest the presence of a terminator site at pksF that prevents the 
elongation of the transcript from pksF to pksJ. To discard the possibility that the RT 
reaction didn’t make sufficiently long cDNA, we use a second reverse primer that 
annealed at pksG. We conducted Exact RT-PCR with several forward primers to walk  
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Figure 3- 4. Putative transcription terminator at pksF.  
(A) Exact RT-PCR was performed to determine RNA transcript length by “walking” 
along the pks gene cluster. Above is depicted the location of the primers forward and 
reverse, the expected length of the transcripts (green), and the putative transcription 
terminator (blue) and native promoter at pksG (red flag). A B. subtilis wild-type strain 
was cultured in CH medium and total RNA extracted to obtain cDNA with a specific 
primer annealing at pksJ, as described in methods. PCR was used to amplify the cDNA 
and samples were run in 0.8% agarose.  A single band of the expected size was found 
when the pks genes were “walked” from pksG-J. Multiple non-specific bands appear 
when the pks genes were “walked” from pksF-pksJ. (B) qRT-PCR of pksR transcript. 
Cartoon depicts the location of a pksE-cfp fusion that contains a Pspac promoter 
dependent of IPTG, and the putative transcription terminator and native promoter at 
pksG. A strain containing a pksE-cfp fusion was cultured in CH medium and IPTG- 
induced after reaching exponential growth. cDNA was obtained as described in methods 
and quantification of pksR transcript was obtained by qRT-PCR.  Data is reported as 
described in Fig. 2-3. No changes were observed in the abundance of pksR transcript 
under induction of IPTG. 
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Table 3- 3. Location of pks genes and other predicted features in B. subtilis str .168 
genomea  
Gene Coordinates Direction -35 signal -10 signal RBS Terminator 
pksB 1781983-1782657 + 1781928-1781934 1781955- 1781958 1781970- 1781976  
pksC 1783033..1783896 + 1782895-1782900 1782915-1782919 1783013-1783018  
pksD 1784403..1785290 + 1784255-1784260 1784272-1784275 1784388-1784394  
pksE 1785290..1787590 +     
acpK 1787654..1787899 +     
pksF 1787880..1789127 +   1787880-1787874 1789046-1789074 
pksG 1789131..1790390 + 1789118-1789125 1789144-1789148 1789339-1789344  
pksH 1790381..1791157 +   1790371-1790376  
pksI 1791200..1791946 +   1791189-1791194  
pksJ 1791994..1807128 +   1791982-1791986  
pksL 1807115..1820728 +   1807422-1807427  
pksM 1820747..1833532 +   1820732-1820739  
pksN 1833603..1850066 +   1833584-1833590  
pksR 1850084..1857712 +   1850068-1850073  
pksS 1857857..1858984 - 1859099-1859104 1859079-1859083 1858986-1858991 1857727-1857750 
aInformation taken from Subtilis database (http://genolist.pasteur.fr/SubtiList/) 
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the chromosome from pksC to pksG. We found amplification of the expected sizes along 
with multiple non-specific bands in all cases (data not shown).  These results suggest 
that transcription read-through may take place between pksF and pksG. However, the 
presence of multiple bands in the transcripts from pksC to pksG may be an indication of 
low template abundance, thus the pksF termination site may interfere to some degree 
with transcription elongation through pksF to pksG.  
To further confirm these results, we hypothesized that if a terminator site were 
present at pksF, an insertion of a strong promoter upstream of this termination site would 
not increase the expression of pksF downstream genes. Therefore we used the strain 
PSK0209 that contains a pksE-cfp translational fusion, and Pspac, a strong IPTG-
inducible promoter, located upstream of the pksF locus (Figure 3-1). We measured the 
abundance of pksR transcript by qRT-PCR (Figure 3-4B).  Abundance of pksR transcript 
was not significantly different when the cells were induced with 1.0 mM IPTG, 
compared to non-IPTG induction or wild type.  This experiment suggests the presence of 
a transcription termination site between pksE and pksR. It could be the predicted pksF 
termination site. However, preliminary data from Winkler lab also suggest the presence 
of termination sites at pksJ (Grace Ellis. Personal communication. Unpublished data). 
More experiments need to be performed to further confirm the termination sites of the 
pks operon.  
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Processive antitermination mediated by the pksC-D intergenic region 
Cis-acting regulatory elements have been found in bacteria for transcriptional 
and post-transcriptional gene regulation (121). In particular, cis-acting regulatory RNAs 
have been found within intergenic regions of gene operons that affect expression of the 
downstream genes (120). Given that PpksD was not active at any condition tested we 
hypothesized that the intergenic region between pksC and pksD (pksC-D IR) might have 
an alternative role rather than acting as a promoter. In collaboration with Wade 
Winkler’s lab (U. Maryland), we predicted that the pksC-D IR might function as a cis-
acting regulatory RNA by promoting transcription antitermination. Therefore, we 
hypothesized that the deletion of pksC-D IR would affect transcription and consequently 
production of bacillaene would be reduced. To test this hypothesis we measured 
production of bacillaene in a strain that contained a deletion of pksC-D IR (∆pksC-D IR). 
We used wild-type strain as positive control and ∆pks and ∆codY mutants served as 
negative controls (see chapter II). Samples were taken from cells growing in CH 
medium at OD600 ~ 2.8 and OD600 ~ 4.5, bacillaene was extracted from supernatants and 
measured by HPLC (Figure 3-6). Production of bacillaene significantly decreased in the 
∆pksC-D mutant when compared to the wild-type strain at both cell culture densities 
sampled (between OD600  = 2.8 and OD600 = 4.5). Next, we substituted the pksC-D IR 
with the EAR element, a cis-RNA regulatory element responsible for processive 
antitermination of the eps operon expression in B. subtilis (120). The EAR insertion was 
able to complement the pksC-D IR deletion and restored production of bacillaene (Fig. 
3-6). Similar levels of bacillaene were detected in the EAR-complemented mutant and 
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wild type strains at OD600 ~ 2.8 but not at OD600 ~ 4.5.  These results suggest that pksC-
D IR is necessary for production of bacillaene. The fact that EAR element was able to 
restore bacillaene production suggest that pksC-D IR might have a similar function as 
EAR, namely, a cis-RNA regulatory element necessary for processive antitermination of 
the pks operon. We have begun to call this region the BAR element (bacillaene-
associated RNA) and further experiments are currently performed to confirm this 
hypothesis. 
 
Discussion 
Long gene operons are common in bacteria to optimize the transcription of 
multiple coding sequences that participate in a similar metabolic pathway (122). Gene 
clusters that encode natural products are some of the longest operons observed in nature. 
In particular, a set of 14 genes of the pks gene cluster (pksB - pksR) spans almost 76 kb 
of B. subtilis genome in the same direction at the positive strand, making the pks genes 
the longest operon in B. subtilis. In this chapter, we investigated the regulatory features 
that activate the co-expression of the pks genes. We found that PpksB, PpksC and PpksS 
simultaneously coordinate the expression of the pks gene cluster at its highest expression 
during vegetative growth (OD600 ~ 1.8). PpksG appears to function as an alternative 
promoter that differentially activates pksG downstream genes in the forespore but not the 
mother cell. Some of our data also suggest a weak transcription terminator site upstream 
of the pksG locus that might be coordinated with activation of PpksG. Finally we report  
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Figure 3- 5. Bacillaene production of B. subtilis NCIB 3610 in CH medium.  
Wild type strain and the mutants ∆pks, ∆codY, ∆pksC-D intergenic region (∆pksC-D) 
and pksC-D::EAR (EAR) were cultured at 30°C. Samples were taken at OD600 ~ 2.8 and 
OD600 ~ 4.5, bacillaene was extracted from supernatants and quantified by HPLC. 
Multiple peaks represent different isoforms of bacillaene as previously confirmed by 
LC-MS (See chapter II). Bacillaene production statistically decreases in the ∆pksC-D but 
it is restored in the EAR mutant. All quantitative data shown are average values with 
standard deviations from triplicates of two independent experiments.  
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the presence of what appears to be a cis-acting regulatory RNA at the intergenic region 
between pksC and pksD. The pksC-D intergenic region appears to be involved in 
processive anti-termination of the transcription from pksC to pksR. To our knowledge, 
this is the first report of a cis-acting regulatory RNA that contributes to the elongation of 
a natural product encoding- gene cluster.  
Transcription of operons is usually initiated with the recognition of a promoter 
located upstream of the first gene of the operon. This first promoter is usually highly 
active and other downstream promoters in the operon modestly contribute to elevate the 
levels of the transcript along the operon (114). In contrast, the proximal promoter of the 
pks operon, PpksB, showed moderate activity, likely contributing to the independent 
expression of pksB. The second promoter of the pks genes, PpksC, showed the highest 
activity suggesting that the pks operon initiates at pksC. In addition, with exact RT-PCR, 
we were able to observe the effect of the putative transcription termination site located 
upstream of pksG. Although this termination site interferes with transcription elongation 
at this location, it does not completely interrupt the formation of the transcript.  
Therefore, our data suggest that PpksC is the proximal promoter of an operon that likely 
extends almost 75 kb, from pksC to pksR.  The weak effect of the transcription 
termination site at the end of pksF may serve to decrease the transcript abundance of 
downstream genes, such as the ones that encode for the complex synthetase (pksJ - 
pksR).  This would be consistent with other studies that have shown that the ratio of the 
protein amount of PksE over PksR is 10 to 100- fold (37). It has been proposed that this 
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ratio is related to the function of the proteins in the synthesis of bacillaene, i.e., fewer 
numbers of PksJ to PksR are required to form the core synthetase, but multiple copies 
from PksB to PksG are needed to function as accessory trans-acting enzymes (37). 
To our surprise, we observe high activity of the internal promoter PpksG only 
inside forespores at early stages of sporulation (S1 – S2). Activity of PpksG may be 
coupled with the transcription termination site at pksF to exclusively promote the 
expression of pksG downstream genes during sporulation, but this hypothesis has yet to 
be tested. If that is the case, the differential expression of genes downstream of the pksG 
promoter within the spores may compartmentalize downstream pksG gene products 
inside the spore, either as RNA or proteins. We attempted to determine if the pks gene 
products compartmentalization was essential for sporulation or germination but no 
differences were found between wild type and the ∆pks mutant under any condition 
tested. This data become more intriguing when taken together with some preliminary 
data that suggest random localization of the Pks megacomplex during vegetative growth 
but specific localization in the membrane near by the forespore, during early stages of 
sporulation (S2 - S3) (Appendix II).  Further research is necessary to elucidate the 
function of the pks genes during or later development of spore formation. 
The apparent processive antitermination role of the BAR element is a novel 
mechanism of genetic control not previously reported for a natural product encoding 
gene cluster. It is possible that BAR functions to promote the readthrough of the 
terminator site at the end of pksF. However, other intrinsic termination hairpins have 
been predicted, in particular, an apparent array of terminators that are located at pksJ 
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(Grace Ellis, Winkler Lab. Personal communication).  Whether the cis-regulatory 
element at pksC-D intergenic region is promoting read-hrough of the terminator at pksF 
or the predicted array of terminators at pksJ is currently under investigation. 
Understanding the regulatory controls for bacillaene will serve as a model for antibiotic 
regulation in many organisms with similar long operons. 
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CHAPTER IV 
REGULATORY FUNCTION OF PksA 
Summary 
The TetR family of transcriptional regulators (TFRs) is widely distributed in 
bacteria and regulates a variety of cellular functions. PksA is a putative TFR presumed 
to control the production of bacillaene by modulating the expression of the pks gene 
cluster in Bacillus subtilis. In chapter II, we showed that PksA is not involved in the 
regulation of the pks genes. In this chapter, we present evidence that suggest that PksA is 
a negative regulator of the expression of ymcC gene, located upstream and divergently 
oriented to pksA. By qRT-PCR, we show that the expression of ymcC is controlled by 
PksA and increases up to 1000-fold in the pksA mutant. We used a YmcC-GFP protein 
fusion to investigate the cellular localization of YmcC. We do not detect YmcC at any 
time during vegetative growth but we observed YmcC localization at the membrane 
during sporulation. A potential function of YmcC during spore maturation or 
germination is proposed.  
 
Introduction 
The ability of bacteria to adapt to the changing conditions of the environment 
mainly depends on their rapid and adaptive changes in expression of their genes. Natural 
environments are dynamic, and changes in temperature, nutrient availability and 
exposure to toxic compounds may occur abruptly (78).  Bacterial cells have evolved 
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mechanisms by which they sense those changes and alter gene expression to 
appropriately respond to them.  Specific gene products are either up regulated or down 
regulated to respond to specific environmental changes. Adaptive gene expression 
requires precise regulation in order to overcome difficult conditions in unstable 
environments (127). A common mechanism used by bacteria to respond to their 
surroundings is through transcriptional regulators that respond to environmental stimuli 
and modulate gene transcription and physiological activity accordingly (113). 
The TetR family of regulators (TFRs) is a common class of transcriptional 
regulators of cellular activities (78, 128, 129). The first transcriptional regulator reported 
in this family was TetR, the repressor of the gene tetA that encodes for tetracycline 
resistance. TetR protein acts as a repressor for both tetR and tetA genes and, in addition, 
has a role in the integration, stabilization, or function of the TetA protein in the 
membrane (130). The N-terminal domain of TetR is a helix-turn-helix DNA-binding 
domain that binds to an operator in the tetA promoter. TetR also has a C-terminal ligand-
binding domain that binds to tetracycline in order to inactivate TetR repression of its 
target (129).  The majority of characterized TFRs function as repressors, though there 
are some TFRs that have been reported as activators, and some others that can act as 
both repressors and activators (130–132). While TetR is still the paradigm for the family, 
it is well known that members of this family are involved in a wider range of regulatory 
activities including central metabolism, pathogenicity and development (129). Still, it is 
estimated that about 25% of TFRs function as regulators of genes encoding efflux pumps 
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that confer antibiotic resistance, making this role the most common one among the TFRs 
(128).   
Two characteristics of the TetR family are conserved so that its family members 
are easily recognized. First, TFRs are almost exclusively α helical and all contain a well-
conserved N-terminal helix-turn-helix DNA binding domain that binds to their target 
gene(s). The C-terminal domain of TFRs is usually highly variable and in the majority of 
the cases interacts specifically with small-molecule ligands, allowing this family to 
respond to a diverse range of stimuli (78).  Second, the orientation and proximity of 
TFRs with respect to their target genes is very predictive of a regulatory relationship. 
TFRs are classified in three major groups according to their proximity and orientation to 
their target genes (128). Type I TFRs show a divergent orientation to at least one of the 
adjacent target genes. Type II TFRs are usually in the same orientation of one or more 
adjacent target genes, which are co-transcribed. Type III TFRs show neither of these 
relationships and regulate genes located in another region of the genome (129). More 
than 50% of TFRs belong to class I, so a TFR that shows divergent orientation to an 
adjacent gene with less than 200 bp of intergenic region is a good candidate for 
regulating the adjacent gene(s) (129).   
PksA was annotated as the TFR of the pks genes in Bacillus subtilis (33, 38–40). 
As mentioned in previous chapters, the pks genes encode for proteins that synthesize a 
small molecule with antibiotic properties called bacillaene. pksA is upstream of a gene 
cluster composed of fifteen genes (pksB-pksS) that is nearly 76 kb long (Fig. 2-
1)(chapter II and references within). Given the pksA gene sequence and its orientation 
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with respect to the pks genes, it was thought that pksA is a class II TFR that controls the 
expression of the pks genes (38–40, 129). However, our analysis of the pks gene 
regulation led us to conclude that PksA is not involved in such regulation (Chapter II). 
Therefore, we hypothesize that PksA is either a class I TFR and is regulating the 
expression of the divergently oriented gene, ymcC, or belongs to the class III TFRs and 
is regulating genes located elsewhere in the B. subtilis genome. 
The purpose of this chapter is to investigate the function of PksA.  Our data 
confirm that pksA encodes a TFR that regulates the expression of the gene adjacent and 
divergently oriented to pksA, ymcC.  PksA functions as a negative regulator of ymcC. 
PksA also represses its own expression. The expression of pksA is constitutive and not 
ymcC transcript or YmcC protein are detected during vegetative growth. In addition, 
deletion or overexpression of YmcC caused no evident phenotype during vegetative 
growth either.  However, YmcC is detected at late stages of sporulation suggesting a 
potential role of YmcC during spore maturation or possibly germination.   
 
Material and methods 
Bacterial strains, primers, media and growth conditions  
The undomesticated strain Bacillus subtilis NCIB 3610 was used for all the 
experiments in this work. Table 4-1 contains a list of the strains used in this study. The 
construction of the transcriptional reporter PpksA-yfp was made using the same methods 
as described in chapter II. The YmcC-GFP protein fusion was generated by cloning 
ymcC into pLM028, which was then integrated into the bacterial genome at the ymcC  
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Table 4- 1.  Bacillus subtilis strains used in this study 
 
 
 
Strain Relevant Genotype  Source 
PDS0066 B. subtilis NCIB3610  wild type Laboratory collection 
PDS0030 B. subtilis NCIB3610 amyE:: PpksA-yfp (cat) Laboratory collection 
PDS0101 B. subtilis NCIB3610 amyE:: PpksA-yfp (cat)  ∆pksA Laboratory collection 
PDS0184 B. subtilis NCIB3610 ∆pksA::kan Laboratory collection 
PDS0479 B. subtilis NCIB3610 ∆pksA::kan lacA::pksA+(mls) Laboratory collection 
PDS0150 B. subtilis NCIB3610 amyE::PpksA  lacI (cat) Laboratory collection 
PDS0389 B. subtilis NCIB3610 ymzD-gfp (spc) Laboratory collection 
PDS0392 B. subtilis NCIB3610 ymzD-gfp (spc) ∆pksA::kan Laboratory collection 
PDS0390 B. subtilis NCIB3610 ymcC:gfp (spc) Laboratory collection 
PDS0391 B. subtilis NCIB3610 ymcC-gfp (spc) ∆pksA::kan Laboratory collection 
PDS0171 B. subtilis NCIB3610 ∆ymcC::kan Laboratory collection 
PDS0255 B. subtilis NCIB3610 ∆ymcC::kan amyE::ymcC+:lacZ (cat) Laboratory collection 
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Table 4- 2. Primers used in this study 
 
 
Name Sequence (5’-3’) 
ymcC-gfp-F accaggaattcactggtgtggacctt 
ymcC-gfp-R gaactctcgagactcctgagattcgc 
ymzD-gfp-F Aggacgaattcttacttttatcgcgg 
ymzD-gfp-R gaactctcgagagctgcttctctatt 
Nth_ymcC_F tgttttggggcttgctgtacgc 
Nth_ymcC_R gaatgccgctcaacgcctcg 
qPCR-ymcC-F gaaattgcgttttgggttgt 
qPCR-ymcC-R ccagttgccgctaacaagat 
rtPCR_pksA_1 gcaaaggaagcaggattgtc 
rtPCR_pksA_2 aatccctcactgcaatgtcc 
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locus. Unless otherwise stated, vegetative growth was performed in CH medium at 37°C. 
Induction of sporulation was performed by centrifuging cells that were growing at 
exponential phase (OD600 between 0.5 – 0.8) in CH medium, and resuspending in 
sporulation medium as described by Sterlini and Mandelstam (125). The initiation of 
sporulation was designated as S0, the time of resuspension. Samples were harvested at 
hourly intervals for eight hours (S0-S7). Table 4-2 contains a list of primers used in this 
study. 
 
Northern blots 
Cells from overnight cultures were inoculated into CH medium at an initial 
OD600 = 0.08, grown at 37 °C with vigorous shaking, and harvested at OD600 = 1.5. Total  
RNA was prepared using an RNeasy Mini Kit (Qiagen), according to the manufacturer’s 
instructions. The resulting RNA sample was run in 1% agarose after denaturation with 
glyoxal and dimethyl sulfoxide, transferred on a nylon membrane (Ambion), and then 
hybridized with an RNA probe for ymcC, as previously described (133). NEBlot 
Phototope kit (NEB) was used for biotinylation-probe labeling and hybridization, 
following the manufacturer instructions. 
 
Quantitative RT-PCR 
Cells from overnight cultures were inoculated into CH medium at initial OD600 = 
0.08, grown at 37 °C with vigorous shaking, and harvested either at early (OD600 = 0.2), 
mid (OD600 = 0.8) and late (OD600 = 1.8) exponential growth, or after four hours of 
  98 
induction under different concentrations of IPTG. Detailed description of the method is 
in chapter II. Briefly, RNAprotect Bacteria Reagent (Qiagen) and RNeasy Mini Kit 
(Qiagene) were used to isolate total RNA, according to the manufacturer’s instructions. 
Subsequently, DNase treatment was performed to the strains using Turbo DNA-free kit 
(Applied Biosystems). Two Steps qRT-PCR was performed with the Thermo Scientific 
DyNAmo Flash SYBR green qRTPCR kit. Total RNA of 200 µg was used as template 
to synthesize cDNA. After the RT step, quantitative PCR was done with 2µL of cDNA, 
using specific target primers (Table 4-2) in a CFX96 Touch Real Time PCR 
thermocycler (BioRad). Either gyrB or rpoB was used as the reference gene as indicated 
in each experiment. The samples were run in triplicate for each target gene and negative 
controls were included for each sample where the reaction contained DNase-treated total 
RNA in place of cDNA. Primer efficiency and Cq values were calculated using the 
software LinReg (73).  
 
Fluorescence microscopy 
Samples from shaken liquid cultures in CH medium were taken for fluorescence 
imaging, centrifuged at 8,000 rpm and washed once with PBS.  To stain the membrane, 
cells were resuspended in 20 µM 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-
hexatriene p-toluenesulfonate TMA (Molecular Probes) or N-(Texas Red sulfonyl)-1,2-
dihexadecanoyl-snglycero-3-phosphoethanolamine, triethylammonium salt (TX-RED) 
(Molecular Probes) as indicated in each experiment. Fluorescence images were captured 
using a Nikon Ti-E inverted microscope equipped with a CFI Plan Apo Lambda DM 
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100X objective, TI-DH Diascopic Illuminator, and a CoolSNAP HQ2 Monochrome 
Camera. Exposure time was 1,000 ms for TMA and varied for YFP and GFP from 
experiment to experiment as indicated in each figure. The NIS-elements AR software 
was used to capture and process the images identically for comparative analysis.    
 
Results 
Bioinformatic analysis 
In our initial purpose of looking for regulators of the pks gene cluster we targeted 
pksA, the first gene of the pks gene cluster that had been annotated as the regulator of the 
pks gene cluster (Chapter II and references within).  PksA has been predicted to belong 
to the TetR family of regulators (TFRs) (129).  Functional domain analysis using the 
modular architecture research tool ScanProsite (http://prosite.expasy.org/scanprosite/) 
identified a region between the residues 8 to 68 of PksA as a helix-turn-helix DNA- 
binding domain (Figure 4-1A). This N-terminal DNA-binding domain is typical of TFR 
family members and represented by conserved motifs or profiles in the public databases 
(129). The C- terminal domain of TFRs usually interacts with at least one ligand, 
altering the regulators ability to bind DNA. In the case of PksA there is not an apparent 
similarity of its C-terminal domains with other TFRs proteins (134). Therefore, 
prediction of ligand candidates has not been proposed. Overall bioinformatics analysis 
based on primary structure predicts that PksA is another member of the family of tetR 
regulators. 
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Figure 4- 1. PksA and YmcC organization and conservation among Bacillus spp.  
(A) PksA aminoacid sequence.  In yellow is the predicted tetR-type domain with HTH 
motif highlighted in red (http://prosite.expasy.org). (B)  pksA, ymcC and ymzD loci in B. 
subtilis. Divergent organization of ymcC and ymzD respect to pksA is shown. Predicted 
promoters and terminators are indicated. A shared promoter for the (+) and (-) strand is 
present between ymcC and pksA.  No terminator region is predicted between ymcC and 
ymzD. (C) PksA is evolutionary conserved among Bacillus spp. Multiple-amino-acid-
sequence alignment of PksA from B. subtilis and the homologous proteins from B. 
amyloliquefaciens FZB42, B. cereus ATCC 10987, B. cereus ATCC14579, B. 
licheniformis ATCC 14580, B. pumilus SAFR-032 obtained using Clustal Omega 
(http://www.ebi.ac.uk/Tools/services/web_clustalo/toolform.ebi).  Mid blue indicates 
percentage of agreement >80%, light blue >60%, light grey >40% and white ≤ 40%. 
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Table 4- 3. Conservation of pksA-ymcC pair among Bacillus sppa 
 
Organism Gene accesion 
numberb 
Protein 
similarity 
Protein 
identity  
Predicted product 
B. subtilis 168 BSU17080 --- --- Transcriptional regulator, 
TetR family 
B. amyloliquefaciens RBAM_009910 85% 66% Transcriptional regulator, 
TetR family 
B. cereus ATCC 10987 BCE_0378 61% 39% Transcriptional regulator, 
TetR family 
B. cereus ATCC 14579 BC_2410 60% 30% Transcriptional regulator, 
TetR family 
B. licheniformis BL02122 63% 41% Putative uncharacterized 
protein 
B. pumilus BPUM_3015 64% 40% Transcriptional regulator 
a Based on http://genodb.pasteur.fr/cgi-
bin/WebObjects/GenoList.woa/wa/goToTaxoRank?level=Bacillus%20subtilis%20168 
b Genolist accession number 
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Given that PksA was the presumptive regulator of the pks genes, we first 
hypothesized that PksA was a type II TFR, a regulator with the same orientation of the 
genes that it regulates. The evidence shown in Chapter II indicated that PksA does not 
regulate bacillaene production. As shown in Figure 4-1B, pksA is adjacent and 
divergently oriented to ymcC gene, a predicted integral inner membrane protein. In 
addition, the intergenic region between the pksA and ymcC genes is 120 bp, suggesting 
that PksA regulates ymcC expression (129). pksA is also evolutionary conserved and 
associated with ymcC in several species of Bacillus (Fig. 4-1C and Table 4-3). PksA 
(RBAM_009910) from B. amyloliquefaciens is 85% similar to PksA in B. subtilis. B. 
cereus, B. lichenimoformis and B. pumilus also have corresponding proteins homologous 
to B. subtilis PksA, with about 60% similarity. Genes homologous to ymcC are adjacent 
to pksA homologous genes in B. amyloliquefaciens, B. lichenimoformis and B. pumilus. 
In B. cereus ATCC 10987, BCE_0379 is the product adjacent to BCE_0378, the 
B.subtilis pksA homologous gene.  Despite having low identity to ymcC, BCE_0379 
shows amino acid sequence similarity to integral membrane proteins, as ymcC does.  
Therefore, we predicted that ymcC is the target of PksA, i.e. PksA is regulating the 
expression of ymcC. 
 
PksA controls the expression of ymcC 
To determine whether PksA is a type I TFR that regulates the expression of 
ymcC, we directly analyzed the levels of ymcC transcripts in a strain that contained a 
deletion of pksA and compared it with wild type.  A 1kb transcript was detected by  
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Figure 4- 2. ymcC is controlled by PksA.  
(A) Northern blot analysis shows that ymcC is detectable only in the absence of PksA. B. 
subtilis wild type strain and a ∆pksA mutant were grown in CH medium at 37°C, and 
total RNA extraction at exponential growth was performed. The arrow indicates the band 
that is detected only in the ∆pksA mutant. (B) qRT-PCR indicates that PksA controls 
ymcC expression. Data are presented as described for Figure 2-3, panel D. The ymcC 
transcript was measured by qRT-PCR in wild type, ∆pksA and the ∆pksA genetically 
complemented mutant (pksA+) strains. The deletion of pksA led to an induction of 
~1000-fold expression of ymcC. Comparison between strains at low (0.2), mid (0.8) and 
high (1.8) OD600 indicates that PksA does not allow expression of ymcC during 
exponential growth. (C). qRT-PCR overexpression of PksA shows a corresponding 
reduction in ymcC expression. Y-axis denotes Normalized Fold Expression for ymcC 
(left) and pksA (right) 
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Northern blotting in the pksA mutant but not in wild type (Figure 4-2A).  However, the 
expected size of ymcC transcript was 558 bp.  Another gene encoding a putative inner 
membrane protein, ymzD, is located downstream and with the same orientation as ymcC 
(Figure 4-1B). ymzD is 456 bp long and no transcription terminator sites are detected in 
the intergenic region between ymcC and ymzD (http://subtiwiki.uni-
goettingen.de/apps/expression/expression.php?search=ymcC). Therefore it is likely that 
ymcC and ymzD are being transcribed as a one single operon and negatively regulated by 
PksA.   
Our Northern blotting suggested that the regulation exerted by PksA on the 
ymcC-ymzD pair is very strong since no detectable levels were found in wild type but a 
strong band appeared in the pksA mutant. To determine the strength of this regulation, 
we performed qRT-PCR analysis of the ymcC target in the pksA mutant and compared it 
to wild type (Figure 4-2B).  Deletion of pksA produced an increase of ~1000-fold in the 
expression of ymcC mRNA transcripts. Complementation of the pksA locus (pksA+) 
restored the repression of ymcC transcript to wild type levels. To determine whether the 
abundance of PksA is correlated with the repression of ymcC, we used a strain that 
contained an IPTG-inducible copy of pksA in the ∆pksA strain and quantitated ymcC 
transcripts at different concentrations of IPTG. As expected, the increasing concentration 
of IPTG elevated the levels of pksA up to 65-fold above the native levels of the wild type 
strain (Figure 4-2C).  In turn, the increasing levels of PksA gradually decreased the 
ymcC mRNA abundance.  These results show that the amount of PksA is related to the 
repression of the ymcC in B. subtilis cells.  
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pksA product negatively controls the expression of its own gene 
Many characterized TFRs are known or believed to be autoregulatory to ensure 
the transcriptional repressor level within optimal concentration limits (78, 129). Given 
the relationship between the amounts of PksA and the level of repression of ymcC, we 
hypothesized that expression of PksA is also precisely regulated to ensure appropriate 
concentration of the repressor.  To corroborate this hypothesis we measured the 
abundance of pksA transcript over time in a wild type strain (Figure 4-3A). qRT-PCR 
results showed virtually unchanged levels of pksA transcript over time. The abundance 
of pksA transcript had a slight induction of ~1.6- fold from early (OD600 = 0.2) to mid 
(OD600 = 0.8) exponential growth and ~3.1- fold from early to late (OD600 = 1.5) 
exponential growth.  These results suggest that PksA concentration is substantially 
uniform during exponential growth.    
To assess whether PksA exerts regulatory activity on its own gene, we isolated 
the 5’UTR of pksA and fused it to the yfp gene to create a fluorescence transcriptional 
reporter.  We introduced this reporter, PpksA-yfp, in a wild type and a ∆pksA background 
(Figure 4-3B). Considerable higher levels of pksA promoter activity were detected by 
fluorescence microscopy in the ∆pksA background compared to wild type. Based on 
these results we concluded that PksA represses the expression of its own gene.  
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Figure 4- 3. PksA regulates its own expression  
(A) qRT-PCR indicates that PksA expression does not dramatically fluctuate over time. 
Data are presented as described for Figure 2-3, panel D. The pksA transcript was 
measured in a wild type strain at early (OD600 = 0.2), mid (OD600 = 0.8) and late (OD600 
= 1.5) exponential growth. Abundance of pksA transcript changed ~3-fold from early to 
late exponential growth. (B) Fluorescence images indicated that activity of pksA 
promoter is higher in the pksA mutant than in the wild type strain suggesting a repressive 
activity of PksA on its own product.YFP (green) and DIC images are shown. Scale bar, 
3 µM.  
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Localization of YmcC is at the membrane 
ymcC encodes a putative integral inner membrane protein 
(http://genodb.pasteur.fr).  Transmembrane spanning domain (TMD) analysis using the 
research tool TMHMM  (http://www.cbs.dtu.dk/services/TMHMM-2.0/) predicts five 
TMDs, in addition to the periplasmic and cytoplasmic loops (Figure 4-4A).  To 
determine whether YmcC localizes in the membrane, we constructed a ymcC-gfp gene 
fusion that was integrated at the ymcC locus. We analyzed the distribution pattern of 
YmcC-GFP at various points of vegetative growth by fluorescence microscopy (Figure 
4-4B). No YmcC-GFP could be detected when cells were harvested during exponential 
or stationary phase (Fig. 4-4B and data not shown).  The same results were seen when 
GFP was fused to YmzD, which is coexpressed with ymcC and is also predicted to be an 
integral membrane protein (Fig. 4-4B and data not shown). These results indicate that 
YmcC and YmzD may not have any role in vegetative growth, at least under the 
conditions we tested.  
We also determined whether the YmcC-GFP and ymzD-GFP fusion proteins 
could be detected during sporulation. We cultured the strains in resuspension medium 
and several time points were analyzed by fluorescence microscopy (Figure 4-4C).  
YmcC-GFP signal was low but observable two hours after the initiation of sporulation 
(S2) and the signal increased slightly over time. YmcC distribution seemed to be equally 
distributed in the mother cell and the forespore but with preferential localization in the 
membrane as it followed the same pattern of signal produced by TMA. These results 
seemed to be consistent with the prediction that YmcC is a membrane protein but better  
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Figure 4- 4. Cellular localization of YmcC. 
(A) Predicted membrane-spanning domains of YmcC 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/). YmcC contains five predicted 
transmembrane helices (red), three regions located inside the cell (blue) and two regions 
that contact the exterior (magenta)  (B) Fluorescence images show no evident 
localization of YmcC in vegetative and sporulation growth. YmcC-GFP signal intensity 
in a wild type background is weak at any time point during exponential growth and spore 
formation. YmcC-YFP (green), cells stained with TMA (red) or TEXAS-RED (red) as 
indicated, and phase contrast images are shown. Scale bar, 3 µM. (C) YmcC-GFP signal 
is observed during sporulation. (D) YmcC-GFP signal in a ∆pksA mutant shows 
localization of YmcC by the cellular membrane.  
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fluorescence signal would be necessary to confirm these observations. No detectable 
levels of YmzD were observed at any time during sporulation so YmzD has no apparent 
role during sporulation either (Data not shown). 
To determine whether we could increase the GFP signal of YmcC and YmzD, we 
introduced the translational fusions YmcC-YFP and YmzD-GFP in two separate ∆pksA 
mutant cell lines. Cells were observed by fluorescence microscopy during vegetative 
growth and spore formation as described above. Fluorescence signal was prominent for 
YmcC, even during vegetative growth (S0) (Figure 4-4D). Fluorescence was detected 
along the membrane, at division septa and sometimes in discrete foci at the mid and pole 
cells.  This pattern of distribution is similar to other proteins that localize in the 
membrane (135–137).  
We attempted to identify the function of YmcC in B. subtilis. Given the 
proximity of pksA and ymcC loci to the pks operon, we first hypothesized that YmcC 
might function as a bacillaene efflux pump. Therefore, we co-cultured Streptomyces sp. 
Mg1 and a B. subtilis strain that contained a ymcC deletion to detect changes in 
competition due to the production of bacillaene. No differences were observed between 
B. subtilis wild type and ∆ymcC regarding the production of bacillaene (data not shown). 
We also used microbial phenotype arrays (http://www.biolog.com) to identify any 
potential phenotype defect related with the deletion of ymcC. We used a wild-type B. 
subtilis strain to compare with the isogenic mutants ∆ymcC, ∆pksA and a 
complementation of ymcC (ymcC+) (Table 4-4). Cellular profiles for hundreds of 
conditions for carbon, nitrogen, phosphorous and sulfur utilization, nutrient stimulation,  
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Table 4- 4. Biolog results summary 
 
Condition ∆ymcC ymcC+ ∆pksA 
Carbon 
Utilization 
-a - - 
Nitrogen 
Utilization 
- - - 
Phosphorous 
and Sulphur 
- - - 
Nutrient 
Stimulation 
- - - 
Osmotic and 
pH 
- - - 
Chemical 
Sensitivity 
Increased resistance to 
oxytetracycline, folate 
antagonists, 
aminoglycosides, 
respiration inhibitors 
Increased resistance for folate 
antagonists, plumbagin, 
aminoglycosides, tetracyclines, 
chloramphenicols, and 
respiration inhibitors 
Increased resistance to 
folate antagonists, 
aminoglycosides, 
a No phenotype differences were found between wild type and the mutant 
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changes in osmotic and pH resistance, and chemical sensitivity (PM1-40) were tested. 
Wild-type and the isogenic mutant strains of B. subtilis showed no growth differences in 
the media and nutrient supplements tested. Chemical sensitivity decreased similarly in 
all the mutants.  We think the changes in the chemical sensitivity phenotype were due to 
the presence of the selection markers that were used to identify the mutants rather than 
an effect of the mutants on the genes under study. Therefore, the phenotype arrays did 
not show any apparent differences that suggested a potential role for YmcC and further 
studies are necessary to determine the function of YmcC.  
 
Conclusions 
We found that the TFR gene pksA encodes a novel negative regulator of ymcC. 
The pksA gene is divergently oriented to ymcC and the intergenic region that separates 
them contains the sequence necessary to repress transcription initiation from the 
promoters of pksA and ymcC. Our data reveals a near 1000-fold repression of ymcC by 
PksA as measured by qPCR. PksA also represses the expression of its own product as 
evidenced by the fluorescence signal differences of the PpksA reporter in the presence and 
absence of the pksA gene.  Other TFR systems, including the tetR-tetA model pair, are 
organized similarly to the pksA-ymcC pair and the region that represses expression of the 
gene pair is an apparent palindromic operator sequence that is bound by a dimeric form 
of the regulator (128).  In the case of the tetR-tetA pair, tetracycline activates tetA 
expression by binding TetR and lowering its affinity for DNA (138). Our data suggest 
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that the pksA-ymcC pair is organized similarly to the tetR-teA pair but further studies are 
necessary to confirm the presence of the palindromic operator sequence.  
Levels of ymcC expression are slightly increased during sporulation according to 
the SubtiExpress database. To assess whether we YmcC could be visualized under native 
conditions during sporulation, we used the YmcC-GFP protein fusion in the wild-type 
background. Fluorescence was detected as early as two hours after beginning of 
sporulation (S2) and the fluorescence signal slightly increased over time. The pattern of 
distribution of YmcC was similar to the pattern observed in the ∆pksA mutant, 
confirming the native localization of YmcC is at the membrane and occurs during spore 
formation. These results are suggestive of a potential role of YmcC during spore 
maturation or possibly germination.   
Given that the production of YmcC mainly occurs at the latest stages of 
sporulation, it is likely that YmcC functions during spore maturation or possibly 
germination. For instance, one possible function based on the localization of YmcC at 
the membrane would be as a specific receptor in response to an appropriate nutrient 
during germination.   In B. subtilis, the operons gerA and gerB have been discovered to 
encode germinant receptors.  The gerA operon encodes three proteins, GerAA, GerAB 
and GerAC (139). These three proteins are integral membrane proteins and GerAA has a 
predicted membrane-bound domain that would span the membrane at least five times, a 
similar pattern as ymcC (140) (Fig. 4A).  Protein receptors are thought to be germinant 
specific but no detailed function of any of the germinant receptor protein has been 
described.  It is known that spore-formers often contain several of these receptor operons 
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and respond to different types of germinant via multiple receptors. It is plausible that 
YmcC is one of those germinant receptors but further studies are required to validate this 
hypothesis.  
Although Northern blotting experiments suggest that ymcC and ymzD are being 
transcribed as one single operon, we were unable to observe YmzD during sporulation, 
as we expected given the results about YmcC localization. Therefore, more experiments 
are needed to confirm whether ymzD is part of the transcript controlled by PksA. If 
coexpression of YmcC and YmzD exist, YmzD may not be a membrane protein as 
predicted but an RNA element that coexpresses with ymcC to increase the level of 
regulation of this system. 
In the regulatory scheme of divergently oriented TFR systems, synthesis of the 
repressor and its regulated protein(s) is simultaneously derepressed in the presence of a 
ligand that binds to the C- terminal domain of the regulator and lowers its affinity to 
DNA (138).  This on/off switch mechanism may be used by PksA to respond to a 
specific signal but until now the ligand has not been identified.  While TFRs can be 
easily identified based on conserved sequence motifs, identifying their cognate ligands is 
more challenging. A recent study has reported the use of a phylogenomics approach to 
organize a TFR database in order to predict cognate ligands for TRFs of unknown 
function (134). Unfortunately, PksA clusters with other unknown TFRs and the only 
ligand predicted to bind this TFR cluster is bacillaene due to the previous misconception 
that pksA is part of the pks gene cluster (See chapter II and references within). More 
studies are required to determine if one or multiple ligands are able to bind PksA to alter 
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its structure and affinity to DNA. If a ligand is part of the regulation of the pksA-ymcC 
pair, we speculate that the ligand must be present at latest stages of sporulation to release 
the repression exerted by PksA. Alternatively, a ligand that binds PksA may be present 
during every other B. subtilis stage except late sporulation, releasing PksA from the 
DNA and acting in this way as a catabolite that increases DNA-affinity of PksA 
(catabolite repressor). 
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CHAPTER V  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Antiobiotic resistance greatly challenges the medical community’s ability to fight 
infectious diseases. After World War II, the stunning success of antibiotics in treating 
infections led to the identification and synthesis of hundreds of different antibiotics 
(141). In part due to increased antibiotic use, the human life expectancy has risen from 
about 40 years to 77 years in the past century (141). However it did not take long to 
recognize that bacteria were able to evade antibiotic effects and undermine their 
efficiency. Resistance mechanisms have emerged and spread globally, resulting in the 
death and disability of thousands of people a year. According to the World Health 
Organization, antibiotic resistance is currently a serious threat to global public health 
(11). In addition, many pharmaceutical firms are eliminating their natural product 
research due to technical limitations in identifying new compounds with desirable 
activity and financial considerations for cost of discovery and development (141).  
Therefore, new approaches need to be investigated to counteract antibiotic resistance. 
One area of investigation could be the understanding of antibiotic resistance from an 
ecological perspective, identifying how antibiotics function and how bacteria respond to 
them in nature (43, 142). Additionally, predictions based on bacterial genome capacity 
suggest that many antibiotics remain to be discovered since the gene clusters that encode 
their synthesis do not become active under laboratory conditions. Therefore, 
  116 
understanding the mechanisms of antibiotic regulation will contribute to activate 
innumerable natural product-encoding gene clusters that remain silent (112). 
Type I trans-AT PKSs are a promising source of antibiotics but the 
transcriptional activation of their gene cluster has been poorly explored (31). Due to 
their modular architecture (see Chapter I), most of the studies in trans-AT PKSs have 
focused on understanding their biosynthetic mechanisms, genome mining, and the 
prediction of products from their orphan clusters (29, 112, 143). This knowledge has 
been useful for the development of combinatorial biosynthesis, an approach to modify 
natural polyketides in order to improve their functionality (143). However, the 
ecological role and regulation of trans-AT PKSs has not been investigated in depth, 
despite the fact that this knowledge may also help to predict novel compounds and 
counteract the emergence bacterial resistance. Bacillaene has been a prototype of trans-
AT PKS systems but the regulation of the pks gene cluster has not been studied (28, 36, 
39–41, 144).  
In this dissertation, I highlighted some of the intricate mechanisms used by B. 
subtilis to regulate the activation of the pks genes and produce bacillaene. I have found 
that multiple regulatory proteins coordinately modulate the expression of the pks genes 
at different stages of B. subtilis development, and discuss this phenomenon from the 
perspective of possible ecological roles during competition (Chapter II). I also proposed 
a more complex regulation of the pks genes that requires the orchestration of several 
regulatory elements. One of these regulatory elements is a cis-RNA element (BAR 
element) that contributes to the transcription elongation of almost 75 kb, a phenomenon 
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not previously reported for regulation of secondary metabolites (Chapter III). Finally, I 
described the role of PksA in regulation of ymcC gene expression, as opposed to the 
previously predicted function as the regulator of the pks genes (Chapter IV). In this 
chapter, I will discuss the conclusions and future directions that may arise from this 
research.  
 
Bacillaene is an essential compound for B. subtilis survival during competition 
The absence of bacillaene dramatically changes the interaction outcomes 
between B. subtilis and Streptomyces spp. Bacillaene was first reported as an inhibitor of 
protein synthesis in bacteria (34). This antibiotic effect seems to be of broad spectrum, 
causing growth inhibition in species such as Escherichia coli, Staphylococcus aeureus, 
Pseudomonas aeruginosa and some species of Streptomyces (34, 37). However, 
bacillaene is an unstable molecule when purified, so it is suspected that the concentration 
of the molecule is low in natural environments (41). In this context, bacillaene may have 
distinct functions as evidenced by the competitive assays between B. subtilis and 
Streptomyces spp (Chapter I). In addition to growth inhibitory activity, previous reports 
have shown that bacillaene interferes with the production of prodiginines by S. 
coelicolor, and in this dissertation I also show the same effect of bacillaene on S. 
lividans (37, 145)(Chapter II). Another outcome is observed in the absence of bacillaene 
during B. subtilis and Streptomyces sp. Mg1. During this interaction, bacillaene not only 
offers some type of protection to B. subtilis from the lytic effects of S. sp. Mg1, but also 
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prevents the competitor from developing aerial hyphae. Therefore, B. subtilis seem to 
gain multiple benefits from bacillaene and its different effects on competitors. 
What functions might bacillaene have during competition? This is a long-
standing question that still remains open. In one case, disruption of bacillaene production 
leads to increased prodiginines productions by S. coelicolor (37). One hypothesis to 
explain this observation is that when bacillaene production is disrupted, B. subtilis 
increases the production of other secondary metabolites. One of these other molecules 
could induce S. coelicolor to make prodiginines (48). On the other hand, the presence of 
bacillaene delays prodiginines production, as observed in S. coelicolor lawns that have 
been exposed to pure bacillaene (Chapter I). However, neither production nor absence of 
prodiginines by S. coelicolor appears to harm B. subtilis. Therefore, the benefits of 
bacillaene as modulator of prodiginines do not seem obvious. I speculate that bacillaene 
must affect other secondary metabolites in S. coelicolor to promote B. subtilis 
competitive advantage. Indeed, this speculation has some precedent established by IMS. 
In the absence of bacillaene, three unknown metabolites are induced in S. coelicolor, in 
addition to prodiginines (48). Whether these unknown metabolites or other undetected 
metabolites harm B. subtilis needs to be determined.   
On the other hand, bacillaene also has a defensive function as revealed by the 
interaction of B. subtilis and S. sp. Mg1 (Chapter I). The protection offered by bacillaene 
resides in its capacity to delay the lytic effect on B. subtilis caused by S. sp. Mg1. In 
contrast, B. subtilis ∆pks strains, which do not produce bacillaene, are rapidly killed and 
lysed by S. sp. Mg1 (Unpublished work by R. Stubbendieck, Straight lab). Moreover, I 
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have also shown that bacillaene is able to inhibit S. sp. Mg1 aerial growth, a 
developmental process required to raise spores (Chapter I). Therefore, bacillaene may 
function by simply delaying spore development, which is usually coordinated with 
antibiotic production in many bacteria (3). Therefore, it is plausible that by inhibiting S. 
sp. Mg1 sporulation, bacillaene is also repressing other unknown secondary metabolites 
that are triggering the lysis of B. subtilis.    
The competition phenotypes between B. subtilis and S. sp. Mg1 discussed in this 
dissertation may provide a better understanding of the mechanisms used by bacillaene to 
counteract B. subtilis competitors. Additional experiments at transcriptional and post-
transcriptional effects of bacillaene on S. sp. Mg1 may provide insights on the 
mechanism of action(s) of bacillaene on this species of Streptomyces. 
 
Bacterial competition enlightens our understanding of the differential activation of 
the pks genes 
The apparent effects of bacillaene during competition prompted us to study the 
mechanisms of regulation used by B. subtilis to activate the pks gene cluster. The results 
of this dissertation support a competition model wherein B. subtilis inactivates bacillaene 
production during a motile phase in the presence of S. lividans while the static colony 
actively expresses the pks genes (Chapter II). The swarming population initially 
repressed pks expression, which over time is activated within the motile populations. 
The cell-type specific expression of the pks cluster raises questions about the ecological 
costs and benefits of producing bacillaene. As described before, production of bacillaene 
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requires a considerable expenditure of energy resources (Chapter I). The flagellar 
machinery is generally used for displacement in order to find new nutritional sources and 
its assemblage also requires significant resources (146). We speculate that maintaining 
low pks gene expression in motile populations may be important for energy resource 
allocation in B. subtilis, because synthesis of bacillaene is likely to require considerable 
energy input. 
Cell specialization is a common mechanism within a B. subtilis population to 
promote division of labor among its members and express developmental features with a 
minimal cost of energy (57, 64). Some examples of this differentiation are spore-forming 
cells, producers of extracellular matrix, genetically competent, and motile cells (64). To 
ensure proper differentiation, each individual cell regulates an intricate transcriptional 
network of proteins that control hundreds of genes to activate or repress specific fates. 
The competitive interactions between B. subtilis and S. lividans allowed us to visualize 
the formation of motile and static subpopulations of B. subtilis (Chapter II). During the 
interactions, motile subpopulations delayed activation of the expression of the pks genes. 
Therefore, we hypothesized that B. subtilis cells used the transcriptional networks for 
cell development to activate the production of bacillaene. 
What model fits the transcriptional network that controls expression of the pks 
genes? I have shown that activation of bacillaene production occurs due to a highly 
coordinated network of master regulators for cell development and nutrient conditions 
(Chapter II) (Fig. 5-1). The development master regulator, Spo0A, and the nutrition 
response regulator, CodY, appear to be the major players in activation of the pks genes.  
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Figure 5- 1. Transcriptional network of the pks genes.  
Multiple regulatory proteins coordinate the expression of the pks genes at the entry into 
stationary phase. These regulators also activate cell development in B. subtilis, leading to 
biofilm, competent and sporulating cells to produce bacillaene. In particular, the nutrient 
response regulator, CodY, and the development master regulator, Spo0A are the major 
regulators of the pks genes. Other master regulators such as DegU, ComA and ScoC are 
also required for full induction.  
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However, ComA, DegU and ScoC are also required for full induction, highlighting the 
complex transcriptional network for pks regulation. 
DNA binding assays are necessary to confirm the master regulators that directly 
bind to the pks genes. There is some precedence that suggest that CodY directly binds 
the pks genes (69). A genome-wide identification of B. subtilis CodY binding sites 
determined that some of the strongest CodY binding sites are located within the pks 
genes (69). Specifically, 20 bp intergenic regions between pksB and pksC, pksE and 
acpK, and inside the coding sequence at pksJ and pksN were found to bind CodY. My 
data identified the promoter element between pksB and pksC that might bind CodY, but 
internal promoters at pksE-acpK and pksJ-pksN cannot be discarded and will need 
further confirmation. Alternatively, these regions may have auxiliary roles in facilitating 
the expression of the distal genes. 
Similarly, a genome-wide binding profile of AbrB found multiple sites 
throughout the pks gene cluster, suggesting that the effect of Spo0A is through AbrB 
(83, 147). The data we present also suggest that activation of the pks genes by Spo0A 
occurs through the repression of the AbrB repressor, confirming the results of the 
previous report (Chapter II). Curiously, in the genome-wide binding profile study all the 
AbrB binding sites in the pks genes are within coding sequences and not in intergenic 
regions (83). AbrB was found to bind regions inside the coding sequence of pksC, pksD, 
pksJ, pksL, pksN and pksR (83). It is possible that AbrB acts as repressor of the pks 
genes by altering the topology of the DNA instead of overlapping promoter or activation 
sites.  However, the same study also shows that the expression of the genes downstream 
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of pksJ, pksL, pksN and pksR are not significantly affected by the binding of AbrB (83). 
It has been previously proposed that AbrB may work as a nucleoid-associated protein 
given that in many other genes the AbrB binding does not affect transcription (83). 
Therefore it is possible that the binding of AbrB at distal pks genes is related to other 
biological functions such as replication and higher order of DNA organization, instead of 
production of bacillaene.   
 
Promoters of the pks genes are dynamically activated at different developmental 
stages 
In addition to the complex regulatory network of proteins that controls the 
expression of the pks genes, this dissertation also highlights the organization of several 
regulatory elements within the pks gene cluster. Four promoters along the pks genes 
control the activation of the pks genes, namely, PpksB, PpksC, PpksG and PpksS. PpksC is the 
most active promoter in vegetatively growing cells. PpksB, PpksC, and PpksS activate the pks 
gene cluster, at the entry into stationary phase. Remarkably, PpksG seems to differ in its 
spatiotemporal activation with respect to the others.  PpksG is activated exclusively at late 
stationary phase and only inside spore-forming cells, but not mother cells.  
Why does activation of PpksG delays up to the entry into sporulation? The pks 
genes are dispensable for sporulation and germination, at least under the conditions I 
tested (Chapter III). However, two types of evidence, transcriptional and cytological, 
suggest a role of Pks enzymes associated with spores. First, PpksG has a binding motif for 
SigF, a transcriptional sigma factor that induces differential expression of genes inside 
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the forespores. This SigF binding motif strongly induces the compartmentalized 
activation of PpksG inside the forespore but not the mother cells, as observed by 
fluorescence microscopy (Chapter III).  These results suggest that expression of genes 
downstream of PpksG is activated in the spores. Second, the Pks enzymatic complex that 
synthesizes bacillaene randomly localizes in the cells during vegetative growth. 
However, during initial stages of sporulation the majority of the Pks enzymatic 
complexes localize near the forespores (Appendix II). Taken together, these results 
suggest that production of bacillaene may have an additional, unknown function related 
with sporulation. Secondary metabolites that increase fitness during sporulation or 
germination are not unprecedented. Antibiotic production is known to be coordinated 
with sporulation for many streptomycetes (3). In some cases, antibiotics protect the 
dormant or germinating spore from consumption by other competitors or delay 
germination of spores until conditions become favorable ((3) and references within). In 
B. subtilis several secondary metabolites have also been shown to function as signaling 
molecules for biofilm formation and sporulation (64). Given the protein inhibitory 
properties of bacillaene, it is plausible to speculate that bacillaene may contribute to 
maintaining the dormancy of the spores and be secreted from them upon activation of 
germination. Therefore, further investigation on these subjects may unveil new functions 
for bacillaene. 
To clarify the function of bacillaene, I propose to determine whether bacillaene is 
able to inhibit germination. Although the ∆pks mutant did not show a dramatic change in 
germination compared to wild type, it is possible that the addition of bacillaene delays 
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the germination and outgrowth of the cells. Bacillaene would need to be purified and 
dilution series may establish the minimal concentration of bacillaene to delay 
germination. 
 
A novel cis-regulatory RNA to elongate the transcription of a long operon 
The intergenic region between pksC and pksD was initially predicted to be a 
promoter of the pks genes but transcriptional reporters with YFP showed no activity, 
negating this hypothesis. However, the deletion of this region led to a significant 
reduction in the production of bacillaene (Chapter IV).  Further analysis performed by 
Winkler lab (U. Maryland) have shown that the function of this intergenic region is to 
readthrough transcription terminators located at the pksJ locus (Grace Ellis, personal 
communication). Taken together, these results suggest a role of the pksC to pksD 
intergenic region as a cis-regulatory RNA that mediates processive antitermination (Fig. 
5-2). We called this region ‘BAR’ (bacillaene-associated RNA). To our knowledge, this 
is the first report of an RNA regulatory element associated to the production of an 
antibiotic and the longest transcript controlled by a cis-RNA element.  
Several questions are currently undergoing further investigation in collaboration 
with Winkler Lab. Is the BAR element specific for processive antitermination of the pks 
genes or promote read-through termination sites in general? Is BAR permanently active 
or there are specific conditions and mechanisms that activate an “on” state? What is the 
structural conformation adopted by BAR and how does conformation cause the read-
through terminators? 
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Figure 5- 2. Model for the processive antitermination promoted by the BAR element.  
The expression of the pksC-pksR transcript (~76 kb) begins with the activation of the 
pksC promoter. Transcription elongation initiates and produces the RNA regulatory 
element at pksC and pksD intergenic region (BAR element). The BAR element is able to 
associate with the RNA polymerase and modifies it to become resistant to downstream 
terminator and pause sites. In the absence of the BAR element, terminators present at the 
pksJ locus truncate the transcription. 
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PksA is not associated to a regulatory function over the pks genes 
The regulation of pks gene transcription was previously assigned to the PksA 
protein, annotated as a TetR-family regulator of pks genes. I have shown that PksA does 
not regulate pks gene expression. Related organisms, such as Bacillus amyloliquefaciens 
FZB42 also produce bacillaene, encoding the enzymatic complex in the bae gene cluster 
(38). In contrast to B. subtilis, the orthologous pksA gene of B. amyloliquefaciens FZB42 
is located almost 1kb apart from the bae biosynthetic gene cluster, suggesting that PksA 
is not a pathway-specific regulator (39). Thus these data support a model for pks gene 
regulation that relies on the global regulatory circuits already described and no pathway-
specific regulator is involved in its regulation. 
 
PksA functions as a TetR-like repressor over ymcC 
I have also shown that the regulatory function of PksA is directed toward an 
adjacent, divergently transcribed gene, ymcC. The function of YmcC is unknown but is 
predicted to be a membrane protein. The data I present indicates that PksA represses 
expression of the ymcC gene during vegetative growth. In addition, localization of 
YmcC is observed during spore formation (Chapter IV). I speculate that the protein is 
involved in some aspect of spore maturation, germination or outgrowth. Further 
experiments are necessary to expand this hypothesis. 
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Conclusions 
In summary, this dissertation contributes to a better understanding of the 
regulation of the pks genes in B. subtilis.  The activation of the pks genes is more 
complex than originally hypothesized. Multiple regulatory proteins converge to activate 
the expression of the pks genes at the entry into stationary phase.  These regulatory 
proteins are master regulators involved in developmental transitions and nutrient stress 
response. Therefore, the activation of the pks genes occur in specialized cells that also 
undergo transitions to competence, biofilm formation or sporulation. In addition, several 
regulatory elements located at the pks genes ensure the transcription of the entire gene 
cluster (~78 kb).  Among these regulatory elements, we found a novel cis-RNA element 
that promotes readthrough of termination sites and guarantees the expression of the 
transcript from pksC to pksR (~76 kb). To our knowledge, this mechanism has not been 
previously reported for a natural product- encoding gene cluster.   Last, the expression of 
the pks genes appears to be more complex during sporulation. Activation of a pksG 
promoter inside the forespores suggests differential expression of the pks genes during 
sporulation. Further experiments are necessary to confirm this hypothesis and understand 
the benefits of this compartmentalization.  
The general model is depicted in Fig. 5-3. During early exponential phase of 
growth, the majority of B. subtilis cells are motile and repress the pks genes, presumably 
by the direct binding of AbrB (64, 83)(Fig. 5-3A). At the entry into stationary phase, the 
pks genes become fully activated (Fig. 5-3B). As nutrients become scarce, B. subtilis  
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Figure 5- 3. General model for the regulation of the pks genes.  
(A) B. subtilis cells growing at early-exponential phase are mainly motile and block the 
expression of the pks genes through the AbrB repressor. (B) At the entry into stationary 
phase, Spo0A is activated and blocks the expression of AbrB, releasing the pks genes for 
activation. CodY is also necessary for pks gene induction. Other transcriptional 
regulators play a secondary role in the expression of the pks genes. Promoters at pksB, 
pksC and pksS become active to express the entire gene cluster. The BAR element is 
transcribed and associates with the RNA polymerase to promoter processive 
antitermination. (C) During sporulation, a promoter at pksG that contains a SigmaF 
motif is recognized by the RNA polymerase and differentially activated inside the 
forespores but not the mother cells.   
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cells differentiate and specialize into developmental pathways, including competence, 
biofilm and sporulation (148). During these developmental stages, several master 
regulators become active (57, 64). The major players in the activation of the pks genes 
are the Spo0A and CodY stationary phase regulators. Secondary control mechanisms 
through DegU, ComA, and ScoC also contribute to pks gene expression. In addition, 
several regulatory elements located at the pks genes ensure the expression of the entire 
gene cluster. Active promoters are present upstream of pksB, pksC and pksS. A BAR 
element located at the intergenic region of pksC and pksD promotes read-through of 
transcription terminators and ensures the transcription from pksC to pksR. Finally, B. 
subtilis appear to differentially regulate the pks genes during sporulation (Fig. 5-3C). 
The exclusive activation of the pksG promoter inside the forespores suggests that pksG 
downstream genes are expressed and their products are compartmentalized inside the 
forespores. 
This dissertation provides insights on the regulation of a trans-AT PKS and 
provides a model to investigate similar gene clusters present in other organisms.  
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APPENDIX I 
PRODUCTION OF BACILLAENE IN ∆pksA MUTANT AND 
CHARACTERIZATION OF SPREADING POPULATIONS OF B. subtilis 
 
 
 
 
Figure AI-1. (A) Production of bacillaene over time in wild type, ∆pksA and pksA+. 
HPLC was performed as described in Materials and Methods. (B) qRT-PCR of pksA, 
pksC and pksR in a strain with PksA under the control of Phyper.  Similar conditions as 
described above were used to determine the mRNA abundance of pksC and pksR after 
overexpression of pksA with 1.0 mM IPTG. 35-fold overexpression of PksA was 
observed when culture cells where induced with IPTG.  No fold changes in mRNA 
abundance of pksC and pksR were found. 
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Figure AI-2. Spreading subpopulation resembles swarming motility (A) Co-culture of S. 
lividans and B. subtilis wild type, ∆srfAA and ∆sigD mutants.  Conditions are similar to 
those described in Figure 2. B. subtilis mutants that lack srfAA or sigD genes were 
unable to spread towards S. lividans  (B) Cells of PDS0430 (Phag-YFP, PpksC-YFP) and 
PDS0432 (PtapA-YFP, PpksC-YFP) were picked using a toothpick from the spreading 
subpopulations and plated on fresh agar medium in parallel with an inoculum from the 
original parent colony. No spreading occurred for either inoculation source and all 
colonies maintained the parent morphology in the absence of S. lividans.  
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APPENDIX II 
LOCALIZATION OF THE Pks ENZYMATIC COMPLEX DURING 
SPORULATION 
 
Figure AII-1. Localization of the Pks enzymatic complex at stationary phase (at OD600 
= 3.17). A B. subtilis strain that contains a translational fusion of YFP to the C-terminal 
end of the PksR protein (PSK0212) was used to visualize the localization of the Pks 
enzymatic complex. Cells were grown in CH medium at 37˚C and samples were taken 
over time to visualize the Pks enzymatic complex by fluorescence microscopy, as 
described in Chapter II and Table A2-1. Pks enzymatic complex randomly locates in the 
vegetative cells (blue head arrows) but seems to have preferential location by the polar 
septum membrane during spore formation (green head arrows).  
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OD600 % PksR-YFP % Forespores  
% Forespore 
with PksR 
% pksR at 
Forespore 
0.66 9 0 0 0 
1.06 9 0 0 0 
1.39 17 0 0 0 
1.44 19 0 0 0 
1.66 49 0 0 0 
1.84 81 0 0 0 
3.17 68 3 100 100 
4.07 63 10 89 89 
5.26 61 3 93 73 
6.46 43 4 81 63 
8.21 66 3 88 50 
 
Table AII-1. Pks enzymatic complex preferentially locates in the membrane between the 
mother cell and the forespore during stationary phase. Cells of the strain PSK0212 were 
grown in CH medium and observed over time under fluorescence microscopy, as 
described in Fig. A2-1. During vegetative growth, the Pks enzymatic complex was 
observed to randomly localize in the cells. Formation spores begun at OD600 = 3.17 and 
preferential location of the Pks enzymatic complex was observed at the polar septum 
membrane (green). The percentage of forespores that harbor the Pks enzymatic complex 
decreased as the culture goes into late stationary phase.  
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Figure AII-2. Localization of Pks enzymatic complex during induction of sporulation. 
Cells of PKS0212 were induced to sporulate and samples were taken hourly to visualize 
under fluorescence microscopy, using the same protocol as in Chapter III and figure 3-
2B. Fluorescence images of PksR-YFP (green) in cells stained with TMA-DPH (red) to 
visualize membranes. Before initiation of sporulation (S0), few vegetative cells had the 
Pks enzymatic complex and it randomly localized. As spore formation developed, more 
cells contained the megacomplex and localization by the polar septum became more 
apparent (S1-S4). Later stages of sporulation (S5- S7) seemed to lack preferential 
localization of the Pks megacomplex. . Scale bar, 3 µM  
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Figure AII-2. Analysis of the localization of the Pks enzymatic complex during 
induction of sporulation. Cells observed under fluorescence microscopy in Fig. A2-2 
were counted and formation of spores and localization of Pks enzymatic complexes were 
calculated and plotted. (A) Percentage of spore formation over time.  (B) Percentage of 
Pks enzymatic complex in vegetative cells and spore-forming cells. (C) Location of Pks 
enzymatic complexes in vegetative cells and spore-forming cells. Taken together, the 
results suggest that the Pks enzymatic complex has a preferential localization at the polar 
septum membrane during S3 and S4 stages of sporulation 
 
